1. Introduction {#sec1-genes-10-00580}
===============

Molecular diagnostic testing for Neurofibromatosis type 1 (NF1; MIM 162200) has improved considerably since identification of the first genotype--phenotype associations and an overlap disease, Legius syndrome (LS; MIM 611431) \[[@B1-genes-10-00580]\]. Both disorders belong to the RASopathies \[[@B2-genes-10-00580],[@B3-genes-10-00580],[@B4-genes-10-00580]\], a group of autosomal dominant and phenotypically overlapping disorders caused by mutations in genes encoding for components of the Ras/ mitogen activated protein kinase (MAPK) signaling pathway.

NF1 is a neurocutaneous condition characterized by multiple café au lait macules (CALMs), axillary and inguinal freckling, cutaneous neurofibromas, and iris Lisch nodules (LNs) \[[@B5-genes-10-00580],[@B6-genes-10-00580]\]. Affected individuals show an increased susceptibility to developing benign tumors, such as plexiform neurofibroma, optic pathway glioma (OPG), and non-optic central nervous system glioma. Less common but potentially serious clinical manifestations are also reported \[[@B5-genes-10-00580],[@B6-genes-10-00580],[@B7-genes-10-00580]\].

With a birth incidence of approximately 1:3000, Neurofibromatosis type 1 is caused by dominantly inherited mutations in *NF1* (MIM 613113) \[[@B8-genes-10-00580]\], a complex gene \[[@B9-genes-10-00580]\] encoding for neurofibromin, a GTPase-activating protein that negatively regulates the Ras/MAPK signaling pathway \[[@B10-genes-10-00580]\]. Diagnosis of NF1 is still performed worldwide using clinical criteria formally codified in 1987 \[[@B6-genes-10-00580],[@B11-genes-10-00580],[@B12-genes-10-00580]\]. Nevertheless, clinical manifestations are variable and age related, with some distinguishing signs such as LNs and cutaneous neurofibromas appearing in late childhood or during puberty, further complicating clinical diagnosis of NF1 in young children, as well as in sporadic cases \[[@B6-genes-10-00580]\]. The differential diagnosis with other RASopathies is sometimes challenging due to the occurrence of signs of Noonan syndrome in NF1 patients (e.g., macrocephaly, Noonan-like facial features, short stature, and learning disabilities), as well as the presence of CALMs associated with some RASopathies (e.g., Noonan and LEOPARD syndromes) \[[@B13-genes-10-00580]\]. Milder NF1 phenotypes with pigmentary manifestations but without neurofibromas or OPG are associated with Met^992^ deletion and Arg^1809^ substitution in neurofibromin \[[@B14-genes-10-00580],[@B15-genes-10-00580],[@B16-genes-10-00580]\]. The 17q11.2 microdeletion fully encompassing *NF1* is known to be linked to a more severe phenotype with dysmorphic facial features, overgrowth or tall-for-age stature, significant delay in cognitive development, large hands and feet, hyper flexibility of joints, muscular hypotonia, and malignancies, such as the development of malignant peripheral nerve sheath tumor (MPNST) \[[@B17-genes-10-00580],[@B18-genes-10-00580]\].

Initially described as an NF1-like phenotype, LS is caused by mutations in *SPRED1* (MIM 609291) \[[@B1-genes-10-00580]\], which encodes Spred1, a member of the Sprouty/Spred protein family \[[@B19-genes-10-00580]\] and, similarly to neurofibromin, a negative regulator of the Ras/MAPK signaling pathway \[[@B20-genes-10-00580],[@B21-genes-10-00580]\]. Legius syndrome is characterized by CALMs and freckling without neurofibromas or other typical NF1 features, such as LNs, bony lesions, and OPGs \[[@B1-genes-10-00580],[@B22-genes-10-00580],[@B23-genes-10-00580]\].

Milder or incomplete NF1 phenotypes observed in young-aged patients, sometimes related to specific mildly pathogenic *NF1* variants, clinically overlap with LS or, in some cases, with other RASopathies and constitutional mismatch repair deficiency (CMMRD; MIM 276300) \[[@B24-genes-10-00580]\], necessitating recourse to molecular testing. In this diagnostic scenario, the increasing use of next generation sequencing (NGS), and particularly customized targeted gene panels, provides the opportunity to investigate these clinically overlapping conditions in a time- and cost-saving manner. The concurrent use of second-level tests, such as multiplex ligation-dependent probe amplification (MLPA) or RNA analysis by RT-PCR and Sanger sequencing, can be useful to highlight specific classes of variants or to precisely characterize the effect of each variant on the protein product.

Here, we report our 10 year experience in molecular diagnosis of NF1 and LS, as well as other neurocutaneous conditions, in a large cohort of mostly pediatric patients. We also discuss how NGS and RNA analysis can improve the genetic characterization of patients, permitting differential diagnosis and guiding clinical follow-up.

2. Materials and Methods {#sec2-genes-10-00580}
========================

2.1. Patient Recruitment and Clinical Classification {#sec2dot1-genes-10-00580}
----------------------------------------------------

A total of 281 subjects, including 164 males (58.4%) and 117 females (41.6%), most of which were children (mean age 14 ± 12 years at the pre-test medical examination), were recruited for this study mainly from the Neurofibromatosis Referral Center at the University of Campania "Luigi Vanvitelli" Department of Pediatrics. They were clinically evaluated according to the NIH diagnostic criteria and classified into six different groups.

Typical pigmentary manifestations (CALMs with or without freckling) were considered as the main clinical sign in children and were combined with distinctive NF1 features (LNs, OPG, bone dysplasia, and neurofibromas), age at the pre-test medical examination, and presence of affected first-degree relatives. Of the 281 subjects involved in this study, 150 received a definite clinical diagnosis of NF1 due to the presence of at least one NF1 distinctive sign and were further molecularly characterized only on the parents' request or in presence of a milder phenotype (*n* = 139; Group 1), or when an *NF1* microdeletion was suspected in the presence of a severe NF1 phenotype (*n* = 11; Group 2).

An age-based categorization was established mainly to prioritize *NF1*/*SPRED1* mutation analysis, relying on the fact that some typical NF1 features, such as LNs and neurofibromas, may not be yet present in children aged \<10 years. A further 44 patients with apparently pigmentary manifestations only, without affected first-degree relatives, and aged ≤ 9 years were prioritized for mutation analysis of *NF1* and, subsequently, *SPRED1* (Group 3), while 51 patients either with pigmentary manifestations only, without affected first-degree relatives, and aged ≥ 10 years (*n* = 31; Group 4), or with at least one affected first-degree relative (*n* = 20; Group 5) were prioritized for mutation analysis of *SPRED1* and subsequently *NF1*. Finally, 36 patients with clinical features suggestive of a RASopathy or other neurocutaneous disorders formed Group 6.

Samples were also collected from patients' affected or unaffected relatives (*n* = 167) when necessary.

Written informed consent for DNA analysis was obtained from all the subjects investigated or from their legal guardians at the pre-test medical examination, including explicit consent for future use of data for research purposes, according to the Declaration of Helsinki. Approval for the study was obtained from the Ethics Committee of the University of Campania "Luigi Vanvitelli" (\#254-05/02/2019).

For each subject, blood samples were collected in PAXgene Blood RNA Tubes (Qiagen, Hilden, Germany) or Tempus Blood RNA Tubes (Life Technologies, Carlsbad, CA, USA) to prevent illegitimate splicing during subsequent RNA extraction and analysis \[[@B25-genes-10-00580],[@B26-genes-10-00580]\]. Genomic DNA was also extracted using standard procedures.

2.2. Primer Design for NF1 and SPRED1 Mutation Screening {#sec2dot2-genes-10-00580}
--------------------------------------------------------

*NF1* pseudogenes occur on different human chromosomes \[[@B27-genes-10-00580]\]. To minimize the amplification of targets other than the expected templates, we used the Primer-BLAST tool (<http://www.ncbi.nlm.nih.gov/tools/primer-blast/>) for primer design.

For RNA analysis of the entire coding sequences of *NF1* and *SPRED1* (RefSeq: NM_000267.3 and NM_152594.3, respectively), we designed primer pairs that amplified partially overlapping fragments of 500--700 bp ([Supplementary Materials Table S1](#app1-genes-10-00580){ref-type="app"}). For both genes, genomic oligonucleotide pairs were also designed to amplify each exon and its intronic flanking regions ([Supplementary Materials Table S2](#app1-genes-10-00580){ref-type="app"}).

2.3. Mutation Screening by RT-PCR {#sec2dot3-genes-10-00580}
---------------------------------

For a large number of subjects investigated, *NF1* and *SPRED1* were analyzed at the cDNA level.

Total RNA was extracted using PAXgene Blood RNA Kit (Qiagen, Hilden, Germany) or Tempus Spin RNA Isolation Kit (Life Technologies, Carlsbad, CA, USA) according to the manufacturers' specifications. RNAs were then retro-transcripted using SuperScript III RT (Invitrogen, Carlsbad, CA, USA) and random primers, according to the manufacturer's instructions. Single-strand cDNAs were used in later experiments.

The RT-PCR was performed in a final volume of 20 μL containing 2 μL cDNA, 1X PCR Buffer II (Applied Biosystems, Foster City, CA, USA), 1 mM MgCl~2~, 1 mM dNTPs, 0.5 μM of each primer, and 0.5 U of AmpliTaq Gold DNA polymerase (Applied Biosystems). Cycling conditions consisted of a first step at 96 °C for 7 min followed by 30 cycles of 30 s at 96 °C, 1 min at 63 °C, and 3 min plus 3 s/cycle at 68 °C.

The RT-PCR products were first analyzed by agarose gel electrophoresis to highlight possible unexpected products. For each sample, overlapping fragments covering the entire *NF1* or *SPRED1* coding sequence were subsequently analyzed by bidirectional sequencing.

2.4. Targeted NGS-Based Mutational Screening {#sec2dot4-genes-10-00580}
--------------------------------------------

To extend mutation analysis to other genes involved in RASopathies, neurocutaneous disorders, and other genetically determined conditions with pigmentary manifestations in pediatric age, we designed a customized target NGS panel using HaloPlex technology (Agilent Technologies, Santa Clara, CA, USA). We selected 35 known disease-causing genes ([Supplementary Table S3](#app1-genes-10-00580){ref-type="app"}). The custom panel design also included genes identified as potential interactors of these 35 disease genes using two different bioinformatic tools, STRING and GeneMania \[[@B28-genes-10-00580],[@B29-genes-10-00580]\]. Only genes matching both tools were added to the design.

Enrichment of target sequences of all selected coding genes was performed using the HaloPlex Target Enrichment System for Illumina (Agilent Technologies, Santa Clara, CA, USA) according to the manufacturer's instructions. For each sample, 200 ng of genomic DNA was digested with eight different restriction enzymes to create the fragment library and hybridized for 16 h to specific probes for Illumina sequencing. After capture of the biotinylated target DNA using streptavidin beads, nicks in the circularized fragments were closed by a ligase. Finally, the captured target DNA was eluted by NaOH and amplified by PCR. The amplified target molecules were purified using Agencourt AMPure XP beads (Beckman Coulter Genomics, Chaska, MN, USA). The enriched target DNA in each library sample was validated and quantified by microfluidic analysis using the Bioanalyzer High Sensitivity DNA Assay Kit and 2100 Bioanalyzer Expert Software (Agilent Technologies). Samples were run on a NextSeq500 System (Illumina, San Diego, CA, USA), generating 150 bp-long paired-end reads.

Generated sequences were analyzed using an in-house pipeline designed to automate the analysis workflow \[[@B30-genes-10-00580]\]. Average coverage for all the experiments was 70× and at least 20× for 98% of the target. Paired sequencing reads were aligned to the reference genome (UCSC, hg19 build) using a Burrows--Wheeler Aligner, and sorted with SAMtools and Picard (<http://picard.sourceforge.net>). Calling of single nucleotide variants (SNVs) and small insertions/deletions (Ins/Del) was performed with the Genome Analysis Toolkit (GATK) \[[@B31-genes-10-00580]\] with parameters adapted to HaloPlex-generated sequences. The called SNVs and Ins/Del variants were annotated using ANNOVAR \[[@B32-genes-10-00580]\], reporting variant position in RefSeq \[[@B33-genes-10-00580]\], amino acid change, presence in dbSNP v151 \[[@B34-genes-10-00580]\], frequency in the NHLBI Exome Variant Server (<http://evs.gs.washington.edu/EVS>), 1000 genomes \[[@B35-genes-10-00580]\], and Exome Aggregation Consortium (ExAC) browser (<http://exac.broadinstitute.org>) projects, multiple cross-species conservation \[[@B36-genes-10-00580]\], and prediction scores of damaging on protein activity \[[@B37-genes-10-00580]\].

2.5. Multiplex Ligation-Dependent Probe Amplification {#sec2dot5-genes-10-00580}
-----------------------------------------------------

To identify complete or partial deletions/duplications in *NF1*, *SPRED1, NF2, TSC1,* and *TSC2* genes, MLPA assays were performed using SALSA MLPA P081/P082 NF1 kit, SALSA MLPA P295 SPRED1 kit, SALSA MLPA P044 NF2 kit, SALSA MLPA P124 TSC1 kit, and SALSA MLPA P337 TSC2 kit, respectively (MRC-Holland, Amsterdam, The Netherlands), according to the manufacturer's recommendations. When *NF1* microdeletions were detected, SALSA MLPA P122 NF1 kit (MRC-Holland) was also used to better define breakpoint boundaries.

Briefly, denatured genomic DNA (100 ng) was added to the MLPA mix and the probes were allowed to anneal overnight before the subsequent ligation reaction was performed. Polymerase chain reaction (PCR) was carried out with 6-carboxyfluorescein (FAM)-labeled primers using 5 μL of the ligation reaction as the template. The PCR products were then separated on an ABI 3130xL automatic DNA sequencer (Life Technologies), including at least three normal DNA samples in each batch of the MLPA assays for the subsequent normalization of results.

The MLPA data analysis was performed using the Coffalyser.Net package (MRC-Holland). Relative amounts of probe-amplified products were compared with reference samples to determine the copy number of target sequences. Values under a threshold of 0.7 and over a threshold of 1.3 for multiple adjacent probes indicate the presence of a deletion or duplication, respectively.

2.6. Real-Time PCR {#sec2dot6-genes-10-00580}
------------------

To confirm copy-number mutations identified by MLPA, quantitative amplification of the specific genomic regions was performed on CFX96 Real-Time PCR Detection System (Bio-Rad Laboratories, Hercules, CA, USA) using iQ SYBR Green Supermix (Bio-Rad Laboratories) according to the manufacturer's instructions. Uracil N-glycosylase (Amperase UNG, Life Technologies) was used to prevent PCR carry-over contamination. Each assay was performed in triplicate and the results were normalized and analyzed using CFX Manager software version 1.5 (Bio-Rad Laboratories, Hercules, CA, USA).

2.7. Validation of Variants by Sanger Sequencing {#sec2dot7-genes-10-00580}
------------------------------------------------

The PCR products were double-strand sequenced using BigDye Terminator sequencing chemistry (Life Technologies) and analyzed on an ABI 3130xL automatic DNA sequencer (Life Technologies, Carlsbad, CA, USA). Automatic variation calling was obtained by analyzing sequencing data (ABI file) using Mutation Surveyor software version 3.24 (SoftGenetics, State College, PA, USA), followed by careful inspection of the electropherograms to minimize variant loss.

3. Results {#sec3-genes-10-00580}
==========

Over the last decade, approximately 600 patients suspected of being affected by NF1 or an NF1-like condition, or by RASopathies and other neurocutaneous disorders, were clinically evaluated at our Neurofibromatosis Referral Center in accordance with the NIH diagnostic criteria. For these patients, genetic testing was proposed whenever it may have been useful to confirm the clinical diagnosis. A total of 281 probands gave their informed consent and were included in this study, and molecular analysis was extended to their affected or unaffected relatives (*n* = 167) when necessary. To optimize the use of genetic testing in discriminating NF1 versus LS and other neurocutaneous disorders in childhood, patients were classified into six groups (see Materials and Methods) and prioritized according to their clinical features.

3.1. Molecular Diagnosis {#sec3dot1-genes-10-00580}
------------------------

Results of molecular diagnosis for each patient group are summarized in [Table 1](#genes-10-00580-t001){ref-type="table"}. The causative variant was detected in 239 out of 281 patients analyzed (85.1%), with only 42 undiagnosed patients (14.9%). Both *NF1* and *SPRED1* were mutated in 73.3% and 2.8% of cases, respectively. The remaining 8.9% presented causative variants in different genes.

In subjects with a clinical diagnosis of NF1 (Groups 1, 2), the mutation detection rate was 98% (147/150), similarly to previously reported findings \[[@B38-genes-10-00580]\]. When pigmentary manifestations were the only early clinical sign (Groups 3--5), the mutation detection rate fell to 69.5% (66/95), with *SPRED1* accounting for around 8.4% (8/95) of identified causative variants. Interestingly, the lowest detection rate (64.5%) was obtained for subjects presenting only CALMs, aged ≥ 10 years at the pre-test medical examination, and without affected first-degree relatives (Group 4). In contrast, subjects presenting only CALMs and with at least one affected first-degree relative (Group 5) achieved a higher mutation detection rate (85%), with *NF1* and *SPRED1* accounting for 55% and 30%, respectively.

In subjects with a clinical suspicion of a RASopathy or neurocutaneous disorder, the mutation detection rate was 72.2% (26/36), with variants distributed in ten different genes, mainly *PTPN11* (22.2%), and with only one causative variant in *NF1* (2.7%).

3.2. NF1 Mutation Screening {#sec3dot2-genes-10-00580}
---------------------------

By combining NGS, direct sequencing of RT-PCR products, and MLPA analysis, we identified 169 different causative variants along *NF1* ([Table A1](#genes-10-00580-t0A1){ref-type="table"}). As expected, 33.1% of these (56/169) were novel variants. Single-nucleotide substitutions and single or very short deletion/insertion of bases accounted for 67.4% (114/169) and 30.2% (51/169) of the identified causative variants, respectively. Wider deletions or duplications at *NF1* locus made up the remaining 2.4%. Excluding this last class of mutations, variants were distributed in almost all *NF1* exons ([Supplementary Materials Figure S1](#app1-genes-10-00580){ref-type="app"}) and only 21 were recurrent variants, being present in at least two unrelated patients.

Base substitutions resulted in 31 nonsense variants (27.2%), three of which were novel, 34 missense variants (29.8%), eight of which were not previously reported, and 42 variants differently affecting splicing (36.8%), mainly resulting in a frameshift of *NF1* coding sequence.

Novel missense variants were further investigated, considering segregation in familial cases or their de novo occurrence. In support of their pathogenic effect, these amino acid changes were predicted to be deleterious by common in silico prediction programs (SIFT, Polyphen-2, and Mutation Taster; [Supplementary Materials Table S4](#app1-genes-10-00580){ref-type="app"}) \[[@B39-genes-10-00580],[@B40-genes-10-00580],[@B41-genes-10-00580]\], and were not annotated in the gnomAD and ExAC browsers \[[@B42-genes-10-00580]\].

Variants affecting mRNA splicing are common in *NF1* \[[@B25-genes-10-00580],[@B38-genes-10-00580]\]. In our study, they represent 25.4% (43/169) of all identified causative variants, with 34 variants differently perturbing canonical splice acceptor or donor sites, five variants within exons creating de novo splice sites and resulting in the loss of a part of the exon, and four deep intronic mutations activating cryptic splice sites ([Supplementary Materials Table S5](#app1-genes-10-00580){ref-type="app"}). This last type would likely be underestimated without RNA analysis. In our cohort of NF1 patients, this class of mutation accounted for 2.4% of all identified variants (4/169), three of which were not previously reported.

Complete *NF1* microdeletion and other rearrangements partially involving *NF1* were detected by MLPA analysis. In line with other reports \[[@B43-genes-10-00580],[@B44-genes-10-00580]\], *NF1* microdeletions at 17q11.2 were present in 4.9% (10/205) of patients with an identified causative variant in *NF1*, while two intragenic deletions of exons 15(11)--36(27b) and exons 28(22)--29(23) and a duplication of exons 37(28)--51(42) in *NF1* were identified in three further patients.

3.3. SPRED1 Mutation Screening {#sec3dot3-genes-10-00580}
------------------------------

We identified eight different causative variants in *SPRED1* ([Table A2](#genes-10-00580-t0A2){ref-type="table"}), three of which were novel. Single nucleotide substitutions resulted in four already reported nonsense variants and one missense variant. We also identified a novel 5 bp deletion in a large family with 10 affected individuals and a novel one-base duplication in another family. The MLPA analysis characterized a sporadic case with an intragenic deletion of the last two exons and the 3'UTR of *SPRED1*.

3.4. Phenotype-Genotype Overview {#sec3dot4-genes-10-00580}
--------------------------------

[Table A3](#genes-10-00580-t0A3){ref-type="table"} summarizes the clinical features of 245 probands suspected of being affected by NF1 or an NF1-like condition evaluated at the pre-test medical examination (T0) and after genetic testing (T1). Based on the NIH diagnostic criteria, a clinical diagnosis of NF1 was achieved in 150 patients (Groups 1 and 2), 99.3% of which presented CALMs either with (78.7%) or without (18%) freckling associated with LNs (55.4%), OPG (14%), bone dysplasia (2%), cutaneous or plexiform neurofibromas (62.7%), or an affected first-degree relative (41.3%). One case (Family ID 108) did not quite meet the NIH diagnostic criteria but was nevertheless included in Group 1 due to the presence of neurofibromas at age 5 months, and minor clinical features such as macrocephaly, nevus anemicus, psychomotor delay, and thorax abnormalities. About 98% of these clinically diagnosed patients presented a causative *NF1* variant that resulted in truncated or absent neurofibromin (75.5%), or in in-frame deletions (10.9%) or single substitutions (13.6%) of amino acids.

The remaining 95 patients (Groups 3--5) only presented CALMs (100%), with (29.5%) or without (70.5%) freckling and were negative for the other NIH diagnostic criteria at the pre-test medical examination. Among these, 75 patients were sporadic cases aged ≤ 9 years (*n* = 44; Group 3) or ≥10 years (*n* = 31; Group 4), while the remaining 20 patients were familial cases (Group 5). In Group 3, a causative variant in *NF1* was identified in 63.6% of patients, resulting in truncated or absent neurofibromin (67.9%), or in in-frame deletions (10.7%) or single substitutions (21.4%) of amino acids. In Group 4, which presented the lowest mutation detection rate (61.3%), *NF1* was still the most commonly involved gene with an increased percentage of variants causing in-frame deletions or single substitutions of amino acids (61.1%) compared to those resulting in truncated or absent neurofibromin (38.9%). Only one causative variant was detected in *SPRED1* (Family ID 157). In Groups 3 and 4, typical NF1 clinical features subsequently appeared in only 11 patients with a causative variant in *NF1* identified by genetic testing (T1). For Groups 3 and 4, 48% of patients (36/75) presented only CALMs without any other typical NF1 feature, even after genetic testing (T1), thus not falling within the NIH diagnostic criteria. Interestingly, a causative variant in *NF1* was identified in 30.6% of cases (11/36). In only one case (Family ID 224) was a causative variant in *SPRED1* detected. Finally, *NF1* and *SPRED1* were similarly mutated in patients from Group 5. Variants in *NF1* (55%) gave rise to truncated or absent neurofibromin in only two patients, while *SPRED1* variants (30%) mainly caused haploinsufficiency. Again, in Group 5, no further typical NF1 clinical features subsequently appeared in patients with an *NF1* variant identified by genetic testing (T1).

Neurofibromatosis bright objects were the most frequently observed of all minor clinical features ([Table A3](#genes-10-00580-t0A3){ref-type="table"}), presenting in 20.8% of cases. Learning disabilities and/or speech problems were found in 18.8% of patients, while thorax abnormalities, macrocephaly, leg length discrepancy, and scoliosis in 16.7%. Noonan-like facial features (7.8%), intellectual disability (6.9%), and behavior problems (5.7%) were also observed. Less common but potentially serious malignancies, including malignant peripheral nerve sheath tumor (MPNST), leukemia, and rhabdomyosarcoma, accounted for 2.9% of cases, while vascular alterations such as Moyamoya syndrome and pulmonary stenosis were observed in 2% and 1.6% of cases, respectively.

3.5. Mutation Screening in Non-NF1 or NF1-Like Conditions and Unsolved Cases {#sec3dot5-genes-10-00580}
----------------------------------------------------------------------------

By combining NGS and MLPA analysis, we also investigated 36 patients with clinical features suggestive of a RASopathy or neurocutaneous disorder (Group 6; [Table A4](#genes-10-00580-t0A4){ref-type="table"}). Among these, 14 patients with RASopathy features presented causative variants in *PTPN11* (8/14), *SOS1* (2/14), *PPP1CB* (1/14), and *NF1* (1/14), 14 patients diagnosed with tuberous sclerosis complex (TSC) showed variants in *TSC1* (3/14) and *TSC2* (5/14), five patients with Neurofibromatosis type 2 or Schwannomatosis presented causative variants in *NF2* (3/5) and *LZTR1* (1/5), while a variant in *PTEN* and *KIT* was identified in two other cases with a clinical diagnosis of Cowden syndrome and Piebaldism. Six of the identified causative variants were not previously reported ([Table A4](#genes-10-00580-t0A4){ref-type="table"} and [Supplementary Materials Table S4](#app1-genes-10-00580){ref-type="app"}). Biallelic germline variants in mismatch repair (MMR) genes are known to be responsible for CMMRD. Although this condition is associated with a broad spectrum of early-onset tumors often associated with NF1 features, especially CALMs \[[@B24-genes-10-00580],[@B45-genes-10-00580]\], no causative variants in MMR genes were found in our cohort.

In 42 unsolved cases, we also investigated for variants in candidate genes, considering different models of inheritance. For one patient only, we identified a rare missense heterozygous variant in *MAPK3* (NM_001109891.1:c.601C\>A; p.Leu201Met) not present in our internal database or in any public databases. Although *MAPK3* encodes for a member of the MAP kinase family \[[@B46-genes-10-00580]\], any pathogenic role for the observed variant is currently only speculative.

4. Discussion {#sec4-genes-10-00580}
=============

In recent years, NGS has greatly improved the molecular diagnosis of inherited diseases, particularly in the case of genetically heterogeneous and clinically overlapping conditions. Our experience further supports the diagnostic value of NGS and shows how a targeted NGS-based entry-level test \[[@B47-genes-10-00580],[@B48-genes-10-00580],[@B49-genes-10-00580]\] combined with RNA and MLPA analysis for a complete molecular characterization \[[@B50-genes-10-00580],[@B51-genes-10-00580]\] achieves a high mutation detection rate and is extremely useful in addressing differential diagnosis of NF1 and overlap diseases. In fact, we obtained a molecular diagnosis in about 85% of cases investigated.

For patients with a clinical diagnosis of NF1 (Groups 1, 2), 98% carried an *NF1* causative variant, resulting in truncated or absent neurofibromin in 75.5% of cases. All subjects presented CALMs, with freckling in 86% of cases, as well as the most common typical NF1 features including neurofibromas (64.7%), LNs (59.4%), and OPG (16%). Recently, causative variants in the cysteine/serine-rich domain (CSRD; residues 543--909) were positively associated with OPG \[[@B52-genes-10-00580]\]. Among the 24 NF1 patients presenting OPG investigated, seven showed an *NF1* variant within the CSRD domain. Intellectual and/or learning disability or speech problems were present in about 26.7% of cases, while 8.7% showed Noonan-like facial features \[[@B53-genes-10-00580]\]. Malignancies and vascular alterations, such as Moyamoya syndrome, were observed in 4% and 4.7% of cases, respectively \[[@B54-genes-10-00580]\]. A large NF1 family with co-occurrence of Moyamoya syndrome in two first cousins (Family ID 16) was recently further investigated by whole exome sequencing, which identified *MRVI1* as a susceptibility gene for Moyamoya syndrome in NF1 \[[@B55-genes-10-00580]\]. Of 11 patients with a more severe NF1 phenotype (Group 2) suggestive of *NF1* microdeletion \[[@B17-genes-10-00580],[@B18-genes-10-00580],[@B56-genes-10-00580]\], a 17q11.2 microdeletion was in fact detected in six cases. Among these, two patients later died from MPNST, frequently seen in NF1 microdeletion patients \[[@B18-genes-10-00580],[@B56-genes-10-00580]\]. Truncating variants were present in four other cases with severe NF1 phenotype, and removed large part of the protein sequence with its functional domains. The remaining patient (Family ID 119) showed an in-frame deletion (p.Tyr1614_Tyr1618del) falling in the Sec14-like domain of neurofibromin. This patient showed moderate intellectual disability with learning difficulties and speech problems, macrocephaly, dysmorphic facial features, tall stature, and skeletal anomalies (leg length discrepancy, dystrophic scoliosis, and vertebral scalloping), a small number of subcutaneous neurofibromas, and medullary unidentified bright objects \[[@B57-genes-10-00580]\]. Interestingly, the Sec14-like domain of neurofibromin interacts with valosin-containing protein (VCP), regulating dendritic spine density \[[@B58-genes-10-00580]\]. Dominantly inherited *VCP* mutations cause inclusion body myopathy with Paget disease of bone and frontotemporal dementia \[[@B59-genes-10-00580]\].

Molecular investigation was critical in achieving a clinical diagnosis for patients with only pigmentary features (CALMs with or without freckling; Groups 3--5); for these patients we were able to detect the causative variant in 69.5% of cases. This result highlights the clinical utility of genetic testing, particularly in pediatric age, even in those cases which do not fall within the NIH diagnostic criteria, driving the patient's clinical early follow-up and management. In sporadic cases (*n* = 75; Groups 3, 4), *NF1* was mutated in 62.7% of patients, with only two (Family ID 157 and 224) presenting a variant in *SPRED1* causing haploinsufficiency. Among the *NF1* variants, 55.3% resulted in haploinsufficiency, while the rest were in-frame deletions or single substitutions of amino acids. Subsequent to genetic testing, additional typical NF1 features (LNs and/or neurofibromas) appeared in 11 NF1 patients, 10 of which had a truncating variant in *NF1*. The remaining NF1 patients presented a mild phenotype, with only CALMs either with or without freckling, in some cases complicated by speech and learning problems, short stature, and macrocephaly. Of these, three cases carried the Arg^1809^ substitution in neurofibromin \[[@B15-genes-10-00580],[@B16-genes-10-00580]\].

The causative variant was detected in 85% of patients with pigmentary manifestations also present in at least one affected first-degree relative (*n* = 20; Group 5), with *NF1* and *SPRED1* similarly involved. Missense variants were the most common type of variants found in *NF1*, with the Arg^1809^ substitution accounting for 45.5% \[[@B15-genes-10-00580],[@B16-genes-10-00580]\]. In Group 5, we also molecularly diagnosed the highest percentage of LS (30%), which appears to be primarily associated with inherited mutant alleles, unlike NF1, in which de novo variants frequently occur.

Noonan-like features can be observed in NF1 patients. A neurofibromatosis-Noonan Syndrome (MIM 601321) was reported \[[@B60-genes-10-00580],[@B61-genes-10-00580]\] and linked to variants in *NF 1* \[[@B53-genes-10-00580]\], but also to the co-occurrence of independent variants in *NF1* and *PTPN11* in the same patient \[[@B62-genes-10-00580],[@B63-genes-10-00580]\]. The NGS analysis excluded additive variants in Noonan syndrome-causing genes in our molecularly diagnosed NF1 patients with combined NF1 and Noonan-like features.

We also extended our investigation to 36 patients with clinical features suggestive of other RASopathies or neurocutaneous disorders (Group 6), identifying a causative variant in line with clinical suspicion in 25 cases ([Table A4](#genes-10-00580-t0A4){ref-type="table"}). In one child (Family ID 284) referred by endocrinologists due to clinical suspicion of Noonan syndrome, we did not find any causative variants in Noonan syndrome-causing genes but, unexpectedly, an unreported and maternally inherited missense variant in *NF1* (p.Glu1198Lys). At genetic counseling, the patient presented CALMs, Noonan-like facial features and habitus (short stature, relative macrocephaly, hypertelorism, thoracic asymmetry, and sternum carinatum). Her mother also presented a very small number of CALMs, mild Noonan-like facial features, soft hands and feet, and short stature. Further investigation of this mild phenotype in other patients with the same *NF1* variant may help characterize a possible genotype-phenotype association. This case is illustrative of the diagnostic overlap between these two conditions, as well as in the recently reported case \[[@B64-genes-10-00580]\] of a child (Family ID 187) carrying an *SOS1* variant inherited from his mother, who initially received a diagnosis of NF1 due to the spinal nerve enlargement resembling neurofibromas.

The combined or alternative use of NGS and RNA analysis was able to precisely characterize the functional effect of each causative variant identified in *NF1* and *SPRED1*, in some cases overcoming the limits of each approach when performed individually. Specifically, some missense or nonsense variants in *NF1* caused exon skipping or generated cryptic splice sites. Moreover, similarly exon-skipped *NF1* transcripts were caused by different genomic variants proximal to the same splice site. For some of these skipped exons, including 15(11), 37(27a), and 46(37), phenotype variability was observed in affected patients. Deep intronic mutations activating cryptic splice sites were only detectable by RNA analysis and accounted for 2.4% of all the causative variants we identified. Conversely, three variants in the first exon of *NF1* causing RNA decay were only detectable by NGS analysis. Considering recently reported (and potential novel) genotype-phenotype correlations \[[@B15-genes-10-00580],[@B16-genes-10-00580],[@B18-genes-10-00580],[@B52-genes-10-00580],[@B65-genes-10-00580],[@B66-genes-10-00580],[@B67-genes-10-00580],[@B68-genes-10-00580]\], evaluating the functional effect of genomic variants can have a positive impact on patients' clinical follow-up.

Of the unsolved cases, only four patients had a definite clinical diagnosis of NF1 due to the presence of typical pigmentary manifestations combined with at least one additional distinctive NF1 clinical feature. One of these (Family ID 114) was subsequently diagnosed as having a mosaic form of NF1 because of the peculiar distribution of CALMs restricted to the right side of the trunk and LNs only in the right eye. As suggested by the lowest detection rate, isolated CALMs (Groups 3--5) are associated with a lower possibility of obtaining a molecular diagnosis. This might be due to mosaicism or to the existence of other genetic causes of isolated pigmentary manifestations yet to be discovered. In Group 6, six unsolved cases had a clinical diagnosis of TSC. However, about 15%--20% of TSC patients may have unidentifiable mutations or a mosaicism \[[@B69-genes-10-00580],[@B70-genes-10-00580]\]. Finally, one patient (Family ID 219) with a clinical diagnosis of Schwannomatosis and negative for mutations in *NF2*, *LZTR1,* and *SMARCB1* is under investigation for a somatic mosaicism in *NF2*.

5. Conclusions {#sec5-genes-10-00580}
==============

Our findings highlight the clinical and diagnostic challenges of a pediatric referral center for neurocutaneous disorders, demonstrating how a combined NGS-based approach can assist clinicians in the diagnosis of NF1 as well as other neurocutaneous disorders and overlapping conditions. We categorized patients based on clinical signs and considered an NF1 diagnosis certain only when other distinctive signs besides CALMs and freckling were present, achieving a very high detection rate and providing a precise characterization of identified causative variants. Our results also highlight how it can still make sense to prioritize patients for *NF1* mutation analysis when presenting only CALMs, typical of NF1 in term of number and diameter, and independently from the age at clinical observation. Our categorization suggests that older patients showing only CALMs tend to remain without a definite molecular diagnosis. The RNA analysis facilitates in interpreting the functional effect of genomic variants and can drive the identification of new genotype-phenotype correlations, potentially impacting on the clinical management of NF1 pediatric patients. Through the sharing of clinical and molecular data among members of the scientific community, we are confident it will be possible to identify novel genotype--phenotype correlations and ultimately improve patient outcomes.

The authors are grateful to patients for their participation and cooperation. We thank Catherine Fisher for the English language revision. This study was partly supported by a grant from the Italian Association of Neurofibromatosis (A.N.F.).
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###### 

Unique variants identified in *NF1* (RefSeq NM_000267.3).

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Family ID ^1^   Group   Exon       Type ^2^   Genomic                                cDNA                                                                                                                               Effect                         Protein                     ClinVar/HGMD/LOVD ID^3^
  --------------- ------- ---------- ---------- -------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------- ------------------------------ --------------------------- -------------------------
  216 (3)         5       01(01)     SNV        3G\>A                                  RNA decay                                                                                                                          RNA decay                      ?                           LOVD: NF1_001130

  220 (1)         1       01(01)     SNV        59A\>C (splicing)                      RNA decay                                                                                                                          RNA decay                      ?                           New

  212 (1)         1       01(01)     SNV        60G\>C (splicing)                      RNA decay                                                                                                                          RNA decay                      ?                           New

  35 (2)          1       02(02)     SNV        128T\>C                                128T\>C                                                                                                                            Missense                       Leu43Pro                    LOVD: NF1_000049

  67 (1)          1       03(03)     SNV        277T\>C                                277T\>C                                                                                                                            Missense                       Cys93Arg                    LOVD: NF1_002264

  294 (1)         3       03(03)     SNV        288+1delG                              288del                                                                                                                             Splicing                       Glu97Asnfs\*6               LOVD: NF1_001615

  81 (1)          3       03(03)     SNV        288+1G\>A (Splicing)                   205_288del                                                                                                                         Splicing                       Arg69_Gly96del              LOVD: NF1_001484

  262 (1)         5       03(03)     SNV        288+4A\>G                              205_288del                                                                                                                         Splicing                       Arg69_Gly96del              LOVD: NF1_000270

  93 (3)          1       03(03)     DIM        289-2956C\>T (cryptic splice site)     288_289insAGTCTCACTCTGCGGCACAGGCTGAAGTGCAGTGGCACCCTCTCGGCTCATTGCAACCTCCACTTCCCGGGTTCAAGCTATTCTCATGCCTCAGCCTCCCAAGTAGCTGGGATTACAG   Intronic cryptic splice site   Gln97Valfs\*8               New

  72 (1)          1       04(04a)    DEL        363del                                 363del                                                                                                                             Frame-shift                    His122Thrfs\*43             New

  31 (1)          1       05(04b)    DEL        499_502del                             499_502del                                                                                                                         Frame-shift                    Cys167Glnfs\*10             LOVD: NF1_000605

  251 (1)         1                                                                                                                                                                                                                                                                  

  2 (1)           1       05(04b)    SNV        574C\>T                                574C\>T                                                                                                                            Nonsense                       Arg192\*                    LOVD: NF1_000702

  68 (1)          1                                                                                                                                                                                                                                                                  

  121 (1)         3       07(05)     SNV        667T\>A                                667T\>A                                                                                                                            Missense                       Trp223Arg                   LOVD: NF1_000800

  128 (1)         3       08(06)     SNV        818T\>C                                818T\>C                                                                                                                            Missense                       Leu273Pro                   New

  221 (1)         1       09(07)     DEL        1019_1020del                           1019_1020del                                                                                                                       Frame-shift                    Ser340Cysfs\*12             LOVD: NF1_000005

  172 (1)         1       10(08)     DEL        1110del                                1110del                                                                                                                            Frame-shift                    Ala371Glnfs\*5              New

  49 (1)          3       10(08)     DEL        1123del                                1123del                                                                                                                            Frame-shift                    Leu375\*                    New

  296 (1)         4       10(08)     SNV        1144T\>C                               1144T\>C                                                                                                                           Missense                       Ser382Pro                   New

  46 (1)          1       10(08)     SNV        1185+1G\>A (splicing)                  1063_1185del                                                                                                                       Splicing                       Asn355_Lys395del            LOVD: NF1_000019

  65 (1)          1                                                                                                                                                                                                                                                                  

  218 (1)         1       10(08)     SNV        1185G\>T (splicing)                    1063_1185del                                                                                                                       Splicing                       Asn355_Lys395del            HGMD: CS147216

  125 (1)         3       11(09)     SNV        1186-3T\>G (splicing)                  1185_1186dup                                                                                                                       Splicing                       Ile396Glufs\*17             New

  292 (1)         1       11(09)     SNV        1198C\>T                               1198C\>T                                                                                                                           Nonsense                       Gln400\*                    LOVD: NF1_000024

  110 (1)         3       11(09)     INS        1243dup                                1243dup                                                                                                                            Frame-shift                    His415Profs\*14             ClinVar: 426651

  23 (2)          1       11(09)     SNV        1246C\>T                               1246C\>T                                                                                                                           Nonsense                       Arg416\*                    LOVD: NF1_000034

  152 (1)         1                                                                                                                                                                                                                                                                  

  45 (1)          3       11(09)     DIM        1260+1604A\>G (cryptic splice site)    1260_1261insCTGACTACATAGAGCACTTTCAAGCATGGACTTGGCACTGCT                                                                             Intronic cryptic splice site   Ser421Leufs\*4              LOVD: NF1_000035

  165 (1)         1       11(09)     SNV        1260+1G\>A                             1260_1261insATAAGTCCAAAAG                                                                                                          Splicing                       Ser421Ilefs\*12             LOVD: NF1_000036

  289 (1)         1       12(10a)    SNV        1261-2A\>C (cryptic splice site)       1261_1284del                                                                                                                       Splicing                       Ser421_Lys428del            LOVD: NF1_000045

  82 (1)          1       12(10a)    SNV        1318C\>T                               1318C\>T                                                                                                                           Nonsense                       Arg440\*                    LOVD: NF1_000052

  153 (1)         1                                                                                                                                                                                                                                                                  

  54 (1)          4       12(10a)    DEL        1329del                                1329del                                                                                                                            Frame-shift                    Phe443Leufs\*30             LOVD: NF1_001174

  52 (1)          1       12(10a)    INS        1378dup                                1378dup                                                                                                                            Frame-shift                    Ile460Asnfs\*10             New

  21 (1)          1       12(10a)    SNV        1381C\>T                               1381C\>T                                                                                                                           Nonsense                       Arg461\*                    LOVD: NF1_000056

  57 (1)          3                                                                                                                                                                                                                                                                  

  144 (3)         1                                                                                                                                                                                                                                                                  

  160 (1)         1       12(10a)    DIM        1393-1554C\>G (cryptic splice site)    1392_1393insTGAAGATTTGTTTACACCAGCATCACTACAAACAATAACGCATTGTGCTTGGACATCACGATGGCTATGATA                                               Intronic cryptic splice site   Ser465\*                    New

  17 (3)          1       13(10b)    DEL        1393-2del                              1393_1527del                                                                                                                       Splicing                       Ser465_Cys509del            LOVD: NF1_000061

  116 (1)         1       13(10b)    INS        1399dup                                1399dup                                                                                                                            Frame-shift                    Thr467Asnfs\*3              LOVD: NF1_002283

  288 (1)         1       13(10b)    DEL        1423del                                1423del                                                                                                                            Frame-shift                    Lys476Asnfs\*22             New

  13 (1)          4       13(10b)    SNV        1466A\>G (cryptic splice site)         1466_1527del                                                                                                                       Splicing                       Tyr489\*                    ClinVar: 354

  222 (1)         1                                                                                                                                                                                                                                                                  

  159 (1)         1       13(10b)    INS        1470_1471insATACG                      1470_1471insATACG                                                                                                                  Frame-shift                    Tyr491Ilefs\*9              New

  132 (2)         1       13(10b)    SNV        1487T\>G                               1487T\>G                                                                                                                           Missense                       Met496Arg                   New

  174 (1)         1       13(10b)    INDEL      1499_1501delinsAAA                     1499_1501delinsAAA                                                                                                                 DelIns                         Ile500_His501delinsLysAsn   New

  107 (1)         2       13(10b)    DEL        1500del                                1500del                                                                                                                            Frame-shift                    His501Metfs\*25             New

  138 (1)         3       13(10b)    DIM        1527+1165T\>A (cryptic splice site)    1527_1528insGATGACATGTTTAACCTTTGTTGAGCTTCTTCAGTCCCTGGAGAGCAGCATCAAGCAAG                                                            Intronic cryptic splice site   Asn510Aspfs\*7              New

  76 (1)          1       14(10c)    DEL        1541_1542del                           1541_1542del                                                                                                                       Frame-shift                    Gln514Argfs\*43             LOVD: NF1_000074

  44 (3)          1       14(10c)    SNV        1595T\>G                               1595T\>G                                                                                                                           Missense                       Leu532Arg                   LOVD: NF1_002498

  5 (1)           4       15(11)     SNV        1642-1G\>A (splicing)                  1642_1721del                                                                                                                       Splicing                       Ala548Leufs\*13             LOVD: NF1_000084

  147 (3)         5       15(11)     SNV        1642G\>T                               1642_1721del                                                                                                                       Splicing                       Ala548Leufs\*13             New

  59 (1)          4       15(11)     SNV        1658A\>G                               1658A\>G                                                                                                                           Missense                       His553Arg                   LOVD: NF1_000091

  186 (1)         1       15(11)     SNV        1721+3A\>G (Splicing)                  1642_1721del                                                                                                                       Splicing                       Ala548Leufs\*13             LOVD: NF1_000101

  85 (1)          1       15(11)     SNV        1721G\>C (Splicing)                    1642_1721del                                                                                                                       Splicing                       Ala548Leufs\*13             New

  150 (1)         1       15-36      DEL        1642-?\_4772+?del\                     1642_4772del                                                                                                                       Intragenic deletion            Ala548Valfs\*9              New
                                                (intragenic deletion ex. 15-36)                                                                                                                                                                                                      

  15 (1)          1       16(12a)    SNV        1748A\>G (cryptic splice site)         1722_1748del                                                                                                                       Splicing                       Ser574_Lys583delinsArg      LOVD: NF1_000110

  102 (2)         1       17(12b)    SNV        1846C\>T                               1846C\>T                                                                                                                           Nonsense                       Gln616\*                    LOVD: NF1_000125

  133 (2)         1       17(12b)    DEL        1863del                                1863del                                                                                                                            Frame-shift                    Cys622Valfs\*9              LOVD: NF1_001427

  168 (1)         2                                                                                                                                                                                                                                                                  

  149 (1)         2                                                                                                                                                                                                                                                                  

  214 (1)         1       17(12b)    SNV        1942G\>T                               1942G\>T                                                                                                                           Nonsense                       Glu648\*                    LOVD: NF1_002848

  55 (2)          1       17(12b)    INS        1995dup                                1995dup                                                                                                                            Frame-shift                    Ser666Leufs\*4              New

  217 (1)         1       18(13)     SNV        2002-10T\>A (cryptic splice site)      2001_2002insACTCTCAG                                                                                                               Splicing                       Asp668Thrfs\*23             New

  8 (1)           1       18(13)     SNV        2002-1G\>A (cryptic splice site)       2002_2011del                                                                                                                       Splicing                       Asp668Glnfs\*17             LOVD: NF1_000143

  192 (1)         1       18(13)     INDEL      2027_2028delinsA                       2027_2028delinsA                                                                                                                   DelIns                         Thr676Asnfs\*12             New

  29 (2)          1       18(13)     INS        2033dup                                2033dup                                                                                                                            Frame-shift                    Ile679Aspfs\*21             LOVD: NF1_000148

  63 (1)          1       18(13)     SNV        2041C\>T                               2041C\>T                                                                                                                           Nonsense                       Arg681\*                    LOVD: NF1_000153

  39 (2)          1       18(13)     INS        2167dup                                2167dup                                                                                                                            Frame-shift                    Val723Glyfs\*3              New

  27 (2)          1       18(13)     SNV        2251G\>C (splicing)                    2002_2251del                                                                                                                       Splicing                       Asp668Glufs\*9              ClinVar: 584927

  209 (1)         1       19(14)     SNV        2266C\>T                               2252_2325del                                                                                                                       Splicing                       Arg752Leufs\*17             LOVD: NF1_000174

  75 (1)          1       19(14)     SNV        2288T\>C                               2288T\>C                                                                                                                           Missense                       Leu763Pro                   LOVD: NF1_000177

  7 (2)           1       19(14)     INS        2307dup                                2307dup                                                                                                                            Frame-shift                    Thr770Hisfs\*6              New

  53 (1)          3       20(15)     SNV        2326G\>A                               2326_2409del                                                                                                                       Splicing                       Trp777_Ala804del            New

  126 (1)         1                                                                                                                                                                                                                                                                  

  184 (2)         1       20(15)     SNV        2339C\>A                               2339C\>A                                                                                                                           Missense                       Thr780Lys                   LOVD: NF1_000190

  234 (2)         1       20(15)     SNV        2339C\>G                               2339C\>G                                                                                                                           Missense                       Thr780Arg                   LOVD: NF1_001397

  6 (3)           1       20(15)     SNV        2351G\>C                               2351G\>C                                                                                                                           Missense                       Trp784Ser                   LOVD: NF1_000196

  33 (2)          1       20(15)     SNV        2352G\>C                               2352G\>C                                                                                                                           Missense                       Trp784Cys                   LOVD: NF1_001853

  106 (1)         4       21(16)     SNV        2540T\>G                               2540T\>G                                                                                                                           Missense                       Leu847Arg                   LOVD: NF1_000229

  188 (1)         1                                                                                                                                                                                                                                                                  

  300 (1)         1       21(16)     SNV        2557C\>T                               2557C\>T                                                                                                                           Nonsense                       Gln853\*                    LOVD: NF1_001222

  241 (1)         1                                                                                                                                                                                                                                                                  

  38 (1)          1       21(16)     SNV        2693T\>C                               2693T\>C                                                                                                                           Missense                       Leu898Pro                   LOVD: NF1_000241

  48 (1)          1       21(16)     SNV        2850+1G\>A (cryptic plice site)        2707_2850del                                                                                                                       Splicing                       Cys904_Val951del            LOVD: NF1_000259

  18 (1)          1       22(17)     SNV        2851G\>T (splicing)                    2851_2990del                                                                                                                       Splicing                       Leu952Cysfs\*22             LOVD: NF1_001526

  190 (2)         1                                                                                                                                                                                                                                                                  

  14 (1)          1       22(17)     SNV        2887C\>T                               2887C\>T                                                                                                                           Nonsense                       Gln963\*                    ClinVar: 233495

  109 (1)         1       22(17)     DEL        2948del                                2948del                                                                                                                            Frame-shift                    Leu983Glnfs\*9              New

  19 (2)          1       22(17)     DEL        2970_2972del                           2970_2972del                                                                                                                       In-frame deletion              Met992del                   LOVD: NF1_000277

  134 (1)         1       23(18)     SNV        3040A\>T                               3040A\>T                                                                                                                           Nonsense                       Lys1014\*                   ClinVar: 431616

  140 (1)         4       23(18)     SNV        3104T\>A                               3104T\>A                                                                                                                           Missense                       Met1035Lys                  New

  245 (1)         4       23(18)     SNV        3106A\>G                               3106A\>G                                                                                                                           Missense                       Lys1036Glu                  New

  182 (1)         1       23(18)     SNV        3113+1G\>A (splicing)                  2991_3113del                                                                                                                       Splicing                       Tyr998_Arg1038del           LOVD: NF1_000306

  230 (1)         3       25(19b)    SNV        3277G\>A (cryptic splice site)         3275_3314del                                                                                                                       Splicing                       Gly1092Aspfs\*7             LOVD: NF1_000340

  74 (1)          1       26(20)     SNV        3326T\>G                               3326T\>G                                                                                                                           Nonsense                       Leu1109\*                   New

  41 (1)          4       26(20)     DEL        3347_3350del                           3347_3350del                                                                                                                       Frame-shift                    Asp1116Alafs\*25            LOVD: NF1_000351

  255 (1)         1                                                                                                                                                                                                                                                                  

  115 (1)         3       26(20)     SNV        3445A\>G                               3445A\>G                                                                                                                           Missense                       Met1149Val                  LOVD: NF1_000356

  215 (1)         3                                                                                                                                                                                                                                                                  

  20 (2)          1       26(20)     SNV        3496+1G\>A                             3315_3496del                                                                                                                       Splicing                       Tyr1106Leufs\*28            HGMD: CS072245

  40 (2)          5       27(21)     DEL        3502_3519del                           3502_3519del                                                                                                                       In-frame deletion              Gly1168_Leu1173del          New

  284 (2)         6       27(21)     SNV        3592G\>A                               3592G\>A                                                                                                                           Missense                       Glu1198Lys                  New

  256 (1)         1       27(21)     SNV        3610C\>G                               3610C\>G                                                                                                                           Missense                       Arg1204Gly                  LOVD: NF1_000372

  104 (1)         1       28(22)     SNV        3826C\>T                               3826C\>T                                                                                                                           Nonsense                       Arg1276\*                   LOVD: NF1_000403

  108 (1)         1                                                                                                                                                                                                                                                                  

  166 (1)         1                                                                                                                                                                                                                                                                  

  225 (1)         1       28-29      DEL        (3708+1_3709-1)\_(3973+1_3974-1)del\   not determined                                                                                                                     Intragenic deletion            ?                           New
                                                (intragenic deletion ex. 28-29)                                                                                                                                                                                                      

  275 (1)         3       29(23)     DEL        3899del                                3899del                                                                                                                            Frame-shift                    Leu1300Profs\*9             New

  180 (1)         1       29(23)     SNV        3916C\>T                               3916C\>T                                                                                                                           Nonsense                       Arg1306\*                   LOVD: NF1_000416

  58 (1)          1       29(23)     DEL        3972del                                3972del                                                                                                                            Frame-shift                    Arg1325Glyfs\*2             New

  247 (1)         1       29(23)     SNV        3974G\>A                               3873_3976del                                                                                                                       Splicing                       Tyr1292Argfs\*7             LOVD: NF1_001992

  129 (1)         1       30(23-1)   INS        4100_4103dup                           4100_4103dup                                                                                                                       Frame-shift                    Tyr1369Phefs\*6             New

  36 (1)          2       32(24)     DEL        4168del                                4168del                                                                                                                            Frame-shift                    Leu1390Serfs\*17            LOVD: NF1_000458

  162 (1)         1       32(24)     SNV        4172G\>C                               4172G\>C                                                                                                                           Missense                       Arg1391Thr                  LOVD: NF1_000461

  285 (1)         1       32(24)     SNV        4269+2T\>C                             not determined                                                                                                                     Splicing                       ?                           New

  261 (1)         5       33(25)     SNV        4276C\>G                               4276C\>G                                                                                                                           Missense                       Gln1426Glu                  LOVD: NF1_001275

  154 (1)         1       33(25)     SNV        4278G\>C                               4278G\>C                                                                                                                           Missense                       Gln1426His                  LOVD: NF1_000483

  32 (4)          5       35(27a)    SNV        4515-21T\>G (splicing)                 4514_4515insTTTGCTGTATCTAG                                                                                                         Splicing                       Arg1505Serfs\*53            New

  16 (13)         1       35(27a)    SNV        4515-2A\>G                             4514_4515insTTTGCTGTATCTGG                                                                                                         Splicing                       Arg1505Serfs\*53            LOVD: NF1_000518

  28 (1)          1       35(27a)    SNV        4537C\>T                               4537C\>T                                                                                                                           Nonsense                       Arg1513\*                   LOVD: NF1_000521

  9 (2)           1       35(27a)    SNV        4637C\>A                               4637C\>A                                                                                                                           Nonsense                       Ser1546\*                   LOVD: NF1_000534

  181 (1)         1       35(27a)    DEL        4644del                                4644del                                                                                                                            Frame-shift                    Phe1548Leufs\*5             New

  66 (1)          1       36(27b)    DEL        4680_4683del                           4680_4683del                                                                                                                       Frame-shift                    Glu1561Asnfs\*5             New

  173 (1)         4       36(27b)    DEL        4691del                                4691del                                                                                                                            Frame-shift                    Lys1564Argfs\*3             New

  70 (1)          4       36(27b)    SNV        4768C\>T                               4768C\>T                                                                                                                           Missense                       Arg1590Trp                  HGMD: CM971051

  4 (1)           1       37(28)     SNV        4780del                                4780del                                                                                                                            Frame-shift                    Thr1594Leufs\*9             New

  119 (1)         2       37(28)     DEL        4840_4854del                           4840_4854del                                                                                                                       In-frame deletion              Tyr1614_Tyr1618del          LOVD: NF1_001657

  89 (1)          1       37(28)     DEL        4914_4917del                           4914_4917del                                                                                                                       Frame-shift                    Lys1640Glyfs\*36            LOVD: NF1_000586

  193 (1)         1       37(28)     SNV        4922G\>A                               4922G\>A                                                                                                                           Nonsense                       Trp1641\*                   LOVD: NF1_001303

  80 (2)          1       37(28)     DEL        4973_4978del                           4973_4978del                                                                                                                       In-frame deletion              Ile1658_Tyr1659del          LOVD: NF1_000597

  95 (2)          4       37-51      DUP        5035-?\_7426-?dup\                     not determined                                                                                                                     Intragenic duplication         ?                           New
                                                (intragenic duplication ex. 37-51)                                                                                                                                                                                                   

  10 (2)          1       38(29)     SNV        5264C\>G                               5264C\>G                                                                                                                           Nonsense                       Ser1755\*                   HGMD: CM001260

  1 (2)           4       38(29)     SNV        5401C\>T                               5401C\>T                                                                                                                           Nonsense                       Gln1801\*                   LOVD: NF1_001390

  101 (2)         5       38(29)     SNV        5425C\>T                               5425C\>T                                                                                                                           Missense                       Arg1809Cys                  LOVD: NF1_000653

  112 (5)         5                                                                                                                                                                                                                                                                  

  178 (2)         5                                                                                                                                                                                                                                                                  

  302 (1)         3                                                                                                                                                                                                                                                                  

  155 (1)         4       38(29)     SNV        5426G\>C                               5426G\>C                                                                                                                           Missense                       Arg1809Pro                  ClinVar: 208855

  124 (3)         5       38(29)     SNV        5426G\>T                               5426G\>T                                                                                                                           Missense                       Arg1809Leu                  LOVD: NF1_000654

  156 (1)         4                                                                                                                                                                                                                                                                  

  229 (1)         5                                                                                                                                                                                                                                                                  

  175 (1)         3       38(29)     SNV        5437T\>C                               5437T\>C                                                                                                                           Missense                       Ser1813Pro                  New

  164 (2)         1       38(29)     SNV        5483A\>T                               5483A\>T                                                                                                                           Missense                       Asp1828Val                  LOVD: NF1_000666

  259 (1)         1       38(29)     SNV        5543T\>A                               5543T\>A                                                                                                                           Nonsense                       Leu1848\*                   LOVD: NF1_000670

  163 (1)         1       39(30)     DEL        5592_5596del                           5592_5596del                                                                                                                       Frame-shift                    Asn1864Lysfs\*26            New

  231 (1)         3       39(30)     SNV        5608C\>T                               5608C\>T                                                                                                                           Nonsense                       Gln1870\*                   ClinVar: 237577

  22 (1)          1       39(30)     SNV        5676G\>T                               5676G\>T                                                                                                                           Missense                       Lys1892Asn                  New

  177 (3)         1       39(30)     SNV        5719G\>T                               5719G\>T                                                                                                                           Nonsense                       Glu1907\*                   ClinVar: 187652

  26 (2)          1       39(30)     DEL        5739del                                5739del                                                                                                                            Frame-shift                    Phe1913Leufs\*8             New

  24 (2)          1       40(31)     SNV        5839C\>T                               5839C\>T                                                                                                                           Nonsense                       Arg1947\*                   LOVD: NF1_000711

  171 (1)         1       40(31)     SNV        5842C\>T                               5842C\>T                                                                                                                           Nonsense                       Gln1948\*                   LOVD: NF1_001913

  151 (1)         1       40(31)     SNV        5928G\>A                               5928G\>A                                                                                                                           Nonsense                       Trp1976\*                   LOVD: NF1_002495

  71 (1)          4       40(31)     SNV        5938G\>C                               5938G\>C                                                                                                                           Missense                       Gly1980Arg                  ClinVar: 457773

  282 (1)         3       41(32)     SNV        5944-1G\>C (cryptic splice site)       5946_5952del                                                                                                                       Splicing                       Thr1983Cysfs\*6             ClinVar: 431977

  135 (1)         3       41(32)     SNV        5944-5A\>G (cryptic splice site)       5943_5944insCTAG                                                                                                                   Splicing                       Ile1982Leufs\*7             LOVD: NF1_001321

  34 (2)          1       42(33)     SNV        6085-2A\>T (splicing)                  6085_6364del                                                                                                                       Splicing                       Val2029Lysfs\*7             LOVD: NF1_001919

  83 (1)          1       42(33)     SNV        6243C\>A                               6243C\>A                                                                                                                           Nonsense                       Y2081\*                     New

  223 (1)         1       42(33)     SNV        6335T\>C                               6335T\>C                                                                                                                           Missense                       Leu2112Pro                  LOVD: NF1_000756

  233 (1)         1       42(33)     SNV        6364+4A\>G                             6085_6364del                                                                                                                       Splicing                       Val2029Lysfs\*7             HGMD: CS941517

  97 (1)          3       43(34)     SNV        6579+1G\>T (splicing)                  6365_6579del                                                                                                                       Splicing                       Glu2122Glyfs\*27            LOVD: NF1_000784

  253 (1)         3       43(34)     SNV        6579+2T\>C                             not determined                                                                                                                     Splicing                       ?                           New

  42 (1)          3       44(35)     SNV        6606C\>A                               6606C\>A                                                                                                                           Nonsense                       Cys2202\*                   LOVD: NF1_001338

  137 (1)         1       44(35)     SNV        6611G\>A                               6611G\>A                                                                                                                           Nonsense                       Trp2204\*                   LOVD: NF1_001584

  170 (1)         3       44(35)     SNV        6641+1G\>C                             6580_6641del                                                                                                                       Splicing                       Ala2194Ilefs\*6             LOVD: NF1_000796

  139 (1)         1       45(36)     DEL        6688del                                6688del                                                                                                                            Frame-shift                    Val2230Serfs\*14            LOVD: NF1_001670

  50 (1)          1       45(36)     SNV        6709C\>T                               6709C\>T                                                                                                                           Nonsense                       Arg2237\*                   LOVD: NF1_000802

  73 (1)          1       46(37)     INS        6791_6792insAA                         6791_6792insAA                                                                                                                     Frame-shift                    Tyr2264\*                   LOVD: NF1_001349

  51 (2)          1       46(37)     INS        6791dup                                6791dup                                                                                                                            Frame-shift                    Tyr2264\*                   LOVD: NF1_000815

  118 (1)         3       46(37)     SNV        6792C\>A\                              6757_6858del                                                                                                                       Splicing                       Ala2253_Lys2286del          LOVD: NF1_000816
                                                (STOP determining splicing)                                                                                                                                                                                                          

  143 (1)         4                                                                                                                                                                                                                                                                  

  176 (1)         1                                                                                                                                                                                                                                                                  

  299 (1)         3       46(37)     SNV        6792C\>G\                              6757_6858del                                                                                                                       Splicing                       Ala2253_Lys2286del          LOVD: NF1_000817
                                                (STOP determining splicing)                                                                                                                                                                                                          

  30 (1)          1       46(37)     SNV        6858+1G\>T (splicing)                  6757_6858del                                                                                                                       Splicing                       Ala2253_Lys2286del          LOVD: NF1_000824

  268 (1)         1       46(37)     SNV        6858+2T\>C                             6757_6858del                                                                                                                       Splicing                       Ala2253_Lys2286del          HGMD: CS073509

  47 (1)          3       47(38)     DEL        6881del                                6881del                                                                                                                            Frame-shift                    Leu2294Profs\*4             LOVD: NF1_001726

  84 (1)          1       47(38)     DEL        6898_6903del                           6898_6903del                                                                                                                       In-frame deletion              Ala2300_Val2301del          New

  88 (2)          1       47(38)     SNV        6955C\>T                               6955C\>T                                                                                                                           Nonsense                       Gln2319\*                   New

  276 (1)         1       47(38)     DEL        6974_6977del                           6974_6977del                                                                                                                       Frame-shift                    Asp2325Valfs\*49            LOVD: NF1_001352

  94 (1)          1       48(39)     INS        7089dup                                7089dup                                                                                                                            Frame-shift                    Asn2364\*                   LOVD: NF1_001359

  183 (1)         1                                                                                                                                                                                                                                                                  

  43 (3)          1       48(39)     DEL        7125del                                7125del                                                                                                                            Frame-shift                    Tyr2377Thrfs\*20            LOVD: NF1_000849

  158 (3)         1                                                                                                                                                                                                                                                                  

  169 (1)         1       49(40)     DEL        7169_7170del                           7169_7170del                                                                                                                       Frame-shift                    Arg2390Asnfs\*10            New

  79 (2)          1       49(40)     SNV        7184T\>C                               7184T\>C                                                                                                                           Missense                       Leu2395Pro                  LOVD: NF1_000857

  227 (1)         1       49(40)     INS        7232dup                                7232dup                                                                                                                            Frame-shift                    Asn2411Lysfs\*16            New

  185 (1)         1       50(41)     SNV        7259C\>A                               7259C\>A                                                                                                                           Missense                       Ala2420Asp                  LOVD: NF1_000867

  3 (1)           1       50(41)     SNV        7285C\>T                               7285C\>T                                                                                                                           Nonsense                       Arg2429\*                   LOVD: NF1_000871

  87 (1)          1                                                                                                                                                                                                                                                                  

  37 (1)          3       51(42)     DEL        7518del                                7518del                                                                                                                            Frame-shift                    Gln2507Asnfs\*20            ClinVar: 237598

  130 (1)         4       52(43)     SNV        not determined                         7553_7675del                                                                                                                       In-frame deletion              Gly2518_Met2558del          

  12 (2)          1       53(44)     DEL        7686del                                7686del                                                                                                                            Frame-shift                    Ile2563Phefs\*40            LOVD: NF1_002529

  25 (2)          1       54(45)     INS        7874_7875dup                           7874_7875dup                                                                                                                       Frame-shift                    Ser2626Profs\*33            New

  103 (1)         1       56(47)     SNV        8051-1G\>C (splicing)                  8051_8097del                                                                                                                       Splicing                       Ser2684Thrfs\*9             New

  260 (1)         4       57(48)     INS        8207_8231dup                           8207_8231dup                                                                                                                       Frame-shift                    Leu2745Serfs\*14            New

  61 (1)          2       all        DEL        -718-?\_8375+?del\                     Microdeletion 17q11.2                                                                                                              Microdeletion 17q11.2          ?                           LOVD: NF1_000001
                                                (Microdeletion 17q11.2)                                                                                                                                                                                                              

  64 (1)          2                                                                                                                                                                                                                                                                  

  69 (1)          2                                                                                                                                                                                                                                                                  

  77 (1)          2                                                                                                                                                                                                                                                                  

  78 (1)          1                                                                                                                                                                                                                                                                  

  99 (1)          2                                                                                                                                                                                                                                                                  

  127 (1)         2                                                                                                                                                                                                                                                                  

  136 (1)         1                                                                                                                                                                                                                                                                  

  211 (1)         1                                                                                                                                                                                                                                                                  

  277 (1)         1                                                                                                                                                                                                                                                                  
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^1^ Number of family members presenting the variant is reported in parentheses. ^2^ Type of variant: SNV = Single-nucleotide variant, DEL = Deletion, DUP = Duplication, INS = Insertion, INDEL = Insertion-deletion, DIM = Deep intronic mutation. ^3^ ID of annotated variants in ClinVar ([www.ncbi.nlm.nih.gov/clinvar](www.ncbi.nlm.nih.gov/clinvar)), Human Genome Variation Database (HGMD; [www.hgmd.cf.ac.uk](www.hgmd.cf.ac.uk)), and Leiden Open Variation Database (LOVD; [databases.lovd.nl/shared/genes/NF1](databases.lovd.nl/shared/genes/NF1)).

genes-10-00580-t0A2_Table A2

###### 

Unique variants identified in *SPRED1* (RefSeq NM_152594.2).

  -----------------------------------------------------------------------------------------------------------------------------------------------
  Family ID ^1^   Group   Exon   Type ^2^   Genomic                         cDNA       Effect        Protein           ClinVar/HGMD/LOVD ID ^3^
  --------------- ------- ------ ---------- ------------------------------- ---------- ------------- ----------------- --------------------------
  11(10)          5       2      DEL        49_53del                        49_53del   Frame-shift   Val17Serfs\*8     New

  224(1)          3       2      SNV        52C\>T                          52C\>T     Nonsense      Arg18\*           LOVD: SPRED1_000177

  92(3)           5       2      SNV        70C\>T                          70C\>T     Nonsense      Arg24\*           LOVD: SPRED1_000014

  179(3)          5       2      SNV        74A\>G                          74A\>G     Missense      Asp25Gly          ClinVar: 391600

  161(2)          5       3      SNV        229A\>T                         229A\>T    Nonsense      Lys77\*           LOVD: SPRED1_000121

  157(1)          4       6--7   DEL        618-?\_\*91+?del\               ?          ?             ?                 New
                                            (intragenic deletion ex. 6-7)                                              

  167(4)          5       7      SNV        973C\>T                         973C\>T    Nonsense      Arg325\*          LOVD: SPRED1_000077

  286(2)          5       7      DUP        993dup                          993dup     Frame-shift   Arg332Thrfs\*12   New
  -----------------------------------------------------------------------------------------------------------------------------------------------

^1^ Number of family members presenting the variant is reported in parentheses. ^2^ Type of variant: SNV = Single-nucleotide variant, DEL = Deletion, DUP = Duplication. ^3^ ID of annotated variants in ClinVar ([www.ncbi.nlm.nih.gov/clinvar](www.ncbi.nlm.nih.gov/clinvar)), Human Genome Variation Database (HGMD; [www.hgmd.cf.ac.uk](www.hgmd.cf.ac.uk)), and Leiden Open Variation Database (LOVD; [databases.lovd.nl/shared/genes/SPRED1](databases.lovd.nl/shared/genes/SPRED1)).

genes-10-00580-t0A3_Table A3

###### 

Clinical features of 245 probands with suspicion of NF1 or an NF1-like condition (the most serious clinical features that could reduce patients' life expectancy are highlighted in bold).

  Group   Family ID   Patient ID   Sex   Molecularly Characterized Affected Relatives   Sporadic (Y/N)   Paternal/Maternal Inheritance   Age (yy:mm)   CALMs (≥6)   Freckling   Lisch Nodules   OPG    Bone Dysplasia   Neurofibromas (Cutaneous or Plexiform)   Other Clinical Features ^1^                                         
  ------- ----------- ------------ ----- ---------------------------------------------- ---------------- ------------------------------- ------------- ------------ ----------- --------------- ------ ---------------- ---------------------------------------- ----------------------------- ------ ------ ------ ------ ---- ---- ------------------------------------------------------
  1       2           4            F     0                                              N                Maternal                        2             12:06        \+          \+              \-     \+               \+                                       \+                            \-     \-     \-     \-     \+   \+   **LGG**, DLL
  1       3           5            M     0                                              N                Maternal                        6:08          14           \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \-   \+   Thor
  1       4           6            M     0                                              N                Paternal                        14:02         18:05        \+          \+              \+     \+               \-                                       \-                            n.a.   n.a.   \-     \-     \-   \-   
  1       6           8            M     2                                              N                Maternal                        6             13           \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \+   \+   DLL, DS, ID
  1       7           10           M     1                                              N                Paternal                        20            22           \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \-   \-   NBOs, Epy
  1       8           12           M     0                                              N                Paternal                        10            19:08        \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \+   \+   DLL
  1       9           13           F     1                                              N                Paternal                        14:09         17           \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \+   \+   UH
  1       10          16           F     1                                              N                Maternal                        10            15:04        \+          \+              \-     \+               \-                                       \-                            \+     \+     \-     \-     \+   \+   NBOs
  1       12          116          M     3 (2 twin)                                     N                Paternal                        10            14:08        \+          \+              \-     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   LD, SP
  1       14          23           M     0                                              Y                                                9:09          11:08        \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \-   \-   
  1       15          24           M     0                                              N                Maternal                        10            11           \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \-   \-   DS
  1       16          26           M     12                                             N                Maternal                        10:01         12:04        \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \+   \+   UH, **MMS**, Thor, NBOs, DLL, PmD, LD
  1       17          37           F     1                                              N                Paternal                        3:01          9:01         \+          \+              \-     \+               \-                                       \-                            \-     \-     \-     \-     \-   \+   LD, NBOs
  1       18          38           F     0                                              N                Paternal                        5:09          8:11         \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \+   \+   Noon, MacroC, SP, Thor
  1       19          40           F     1                                              N                Maternal                        12:01         15:08        \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \-   \-   Noon, MacroC, SP, Thor, SS, BvP, BP,
  1       20          41           M     1                                              N                Maternal                        11            19           \+          \+              n.a.   n.a.             \+                                       \+                            \-     \-     \-     \-     \-   \-   Thor
  1       21          43           M     0                                              N                Paternal                        21:11         22:08        \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \+   \+   
  1       22          45           M     0                                              N                Maternal                        14:08         15:06        \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \+   \+   
  1       23          48           F     1 (twin)                                       Y                                                15            17:06        \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \+   \+   DS, DE, VS, LD, SP
  1       24          50           M     1                                              N                Maternal                        13:09         17:06        \+          \+              \+     \+               n.a.                                     n.a.                          \+     \+     \-     \-     \+   \+   SS, DE, DS, NBOs
  1       25          51           F     1                                              N                Maternal                        11:02         11:07        \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \-   \-   
  1       26          53           F     1                                              N                Maternal                        6:01          10           \+          \+              \-     \+               \-                                       \-                            \-     \-     n.a.   n.a.   \-   \-   LD
  1       27          54           M     1 (twin)                                       Y                                                15:03         18:11        \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \-   \+   Thor
  1       28          56           F     0                                              N                Maternal                        7             8:11         \+          \+              \+     \+               n.a.                                     n.a.                          \-     \-     \-     \-     \+   \+   
  1       29          58           F     1                                              N                Paternal                        19:04         22:11        \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \+   \+   DS, NBOs
  1       30          61           M     0                                              N                Paternal                        11:09         13:01        \+          \+              \+     \+               \-                                       n.a.                          \-     \-     \-     \-     \-   \-   Thor
  1       31          62           M     0                                              N                Paternal                        9:07          10:03        \+          \+              \+     \+               \+                                       \+                            \+     \+     \-     \-     \-   \-   DLL, NBOs
  1       33          65           F     1                                              N                Paternal                        14:02         14:08        \+          \+              \+     \+               \+                                       \+                            n.a.   n.a.   \-     \-     \-   \-   SS, DLL, MacroC, DS, Noon
  1       34          66           M     1                                              N                Maternal                        14:05         16           \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \-   \-   **MMS**
  1       35          67           F     1                                              N                Paternal                        22            27           \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \+   \+   
  1       38          72           F     0                                              N                Paternal                        6:04          7:05         \+          \+              \-     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   NA, MacroC
  1       39          76           M     1                                              N                Maternal                        8:06          9:05         \+          \+              \+     \+               n.a.                                     n.a.                          n.a.   n.a.   \-     \-     \-   \-   BP
  1       43          88           F     2                                              N                Maternal                        7             8:01         \+          \+              \+     \+               \-                                       \-                            \+     \+     \-     \-     \+   \+   **Leuk**, DLL, MacroC, NBOs
  1       44          91           M     2                                              N                n.a.                            35            36           \+          \+              \+     \+               \-                                       \-                            n.a.   n.a.   \-     \-     \+   \+   
  1       46          93           M     0                                              Y                                                14            18           \+          \+              \+     \+               \-                                       \+                            \-     \-     \-     \+     \+   \+   Thor, DS
  1       48          99           F     0                                              Y                                                20:01         21:09        \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \+   \+   
  1       50          101          M     0                                              Y                                                4             6:06         \+          \+              \-     \+               \+                                       \+                            \-     \+     \-     \-     \+   \+   SS, NBOs
  1       51          102          F     1                                              N                Maternal                        5             7:08         \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \+   \+   
  1       52          104          F     0                                              Y                                                13            14:02        \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \-   \-   BvP, NA, LD, SP, **CD**
  1       55          107          M     1 (twin)                                       Y                                                9:02          14:04        \+          \+              \+     \+               \+                                       \+                            \-     \+     \-     \-     \+   \+   DLL, NBOs
  1       58          112          F     0                                              N                Maternal                        7             10           \+          \+              \+     \+               \+                                       \+                            n.a.   n.a.   \-     \-     \+   \+   mild ID
  1       63          125          F     0                                              Y                                                16:04         16:07        \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \+   \+   DLL, NBOs, Thor, MacroC
  1       65          128          F     0                                              Y                                                12            19:02        \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \+   \+   LD, DS, NBOs, Thor
  1       66          129          M     0                                              Y                                                7             13:03        \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \+   \+   
  1       67          130          M     0                                              Y                                                12            13:03        \+          \+              \+     \+               n.a.                                     n.a.                          \-     \-     \-     \-     \+   \+   
  1       68          132          M     0                                              Y                                                7             13:06        \+          \+              \-     \-               \+                                       \+                            \-     \-     \-     \-     \+   \+   DLL, NBOs
  1       72          137          M     0                                              Y                                                21            22:02        \+          \+              \+     \+               \+                                       \+                            \-     \-     \+     \+     \-   \-   
  1       73          138          F     0                                              Y                                                17:03         19:05        \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \+   \+   MacroC
  1       74          139          F     0                                              Y                                                12:04         13:04        \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \+   \+   NBOs, LD, SP
  1       75          140          M     0                                              N                Maternal                        6:05          8:02         \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   Thor, LD, NBOs
  1       76          141          F     0                                              Y                                                9:09          12:03        \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \+   \+   DLL
  1       78          149          F     0                                              Y                                                16            18           \+          \+              n.a.   \+               \-                                       \+                            \-     \-     \-     \-     \+   \+   
  1       79          151          M     1                                              N                Maternal                        5:06          8:05         \+          \+              \+     \+               \-                                       \+                            \-     \+     \-     \-     \+   \+   NBOs, CIm, SP, DS, Cry, Noon
  1       80          155          M     1                                              N                Paternal                        4:03          5:05         \+          \+              \-     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   NBOs, ID
  1       82          158          M     0                                              N                Maternal                        4:11          5:11         \+          \+              \-     \-               \-                                       \+                            \-     \-     \-     \-     \-   \-   DLL
  1       83          160          F     0                                              Y                                                8             9:07         \+          \+              \+     \+               \-                                       \+                            \-     \-     \-     \-     \+   \+   NBOs, BvP
  1       84          161          F     0                                              Y                                                23:01         25:11        \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \--    \+   \+   NBOs
  1       85          162          F     0                                              N                Paternal                        1:11          3:01         \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   MacroC, UH
  1       87          171          F     0                                              N                Paternal                        7             8:01         \+          \+              \+     \+               \-                                       \+                            \-     \-     \-     \-     \+   \+   DS, DE, VS, LD, SP, DLL,
  1       88          253          F     1                                              N                Maternal                        7:06          8:06         \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \-   \-   NBOs
  1       89          175          F     0                                              Y                                                20            21           \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \-   \-   LD, NBOs
  1       93          185          M     2                                              N                Maternal                        7:06          11           \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \+   \+   PmD, SP
  1       94          187          M     0                                              N                Maternal                        15            18:04        \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   BvP
  1       98          204          F     0                                              N                Paternal                        13:06         16:06        \+          \+              \+     \+               \+                                       \+                            \-     \+     \-     \-     \+   \+   DS
  1       102         218          F     1                                              N                Maternal                        25            27           \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   Myo, MLyn
  1       103         220          F     0                                              Y                                                21            23           \+          \+              \-     \-               \+                                       \+                            \-     \-     \-     \-     \+   \+   SF
  1       104         223          F     0                                              Y                                                15            16:05        \+          \+              \+     \+               n.a.                                     n.a.                          \-     \-     \-     \-     \+   \+   NBOs, BvP, MacroC
  1       108         228          M     0                                              Y                                                0:05          3:05         \-          \+              \-     \+               \-                                       \-                            \-     \-     \-     \-     \+   \+   NA, MacroC, Thor, PmD
  1       109         236          M     1                                              N                Maternal                        12:07         13:01        \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \+   \+   
  1       114         247          M     0                                              Y                                                18            21:08        \+          \+              \-     \-               \+                                       \+                            \-     \-     \-     \-     \-   \-   
  1       116         250          M     0                                              Y                                                12:03         13:03        \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \+   \+   
  1       126         271          M     0                                              N                Maternal                        4:05          5:03         \+          \+              \-     \-               \+                                       \+                            \+     \+     \-     \-     \+   \+   UH, NBOs, BvP, LD
  1       129         276          M     0                                              Y                                                6:04          7            \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \+   \+   PmD, DLL, Epy
  1       132         286          M     1                                              N                Paternal                        11:09         12:01        \+          \+              \+     \+               \+                                       \+                            \+     \+     \-     \-     \-   \-   NBOs, SP, PmD
  1       133         287          F     1                                              N                n.a.                            1             1:06         \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \-   \-   Noon
  1       134         289          M     0                                              Y                                                10            10:08        \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \-   \-   
  1       136         291          M     0                                              Y                                                15:05         15:09        \+          \+              \+     \+               n.a.                                     n.a.                          \-     \-     \-     \-     \+   \+   LD, PmD, SD, NBOs, BvP, SF
  1       137         309          F     0                                              Y                                                0:08          1:01         \+          \+              \-     \-               \-                                       \-                            \-     \-     \-     \-     \+   \+   
  1       139         301          M     1                                              N                n.a.                            30:06         31:02        \+          \+              \-     \-               \+                                       \+                            \-     \-     \-     \-     \+   \+   
  1       144         317          F     2                                              N                Maternal                        30            30:03        \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \+   \+   MacroC, Noon
  1       150         325          M     0                                              Y                                                11:11         13           \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \+   \+   BSL, LD
  1       151         326          F     0                                              Y                                                14:01         14:08        \+          \+              \+     \+               \+                                       \+                            \+     \+     \-     \-     \-   \-   **MMS**
  1       152         328          M     0                                              Y                                                13            14:06        \+          \+              \+     \+               \+                                       \+                            \+     \+     \-     \-     \-   \-   
  1       153         329          M     0                                              Y                                                19            19:6         \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \-   \-   
  1       154         331          M     0                                              Y                                                20            20:06        \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \+   \+   
  1       158         341          F     2                                              N                Maternal                        15:03         15:09        \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \-   \-   
  1       159         343          M     0                                              Y                                                14:11         15:05        \+          \+              \+     \+               \+                                       \+                            \+     \+     \-     \-     \-   \-   
  1       160         385          M     0                                              Y                                                29:01         30           \+          \+              \-     \-               \+                                       \+                            \-     \-     \-     \-     \-   \-   PS, **CD**, MacroC, Noon
  1       162         354          F     0                                              Y                                                42:06         43           \+          \+              \+     \+               n.a.                                     n.a.                          \-     \-     \-     \-     \+   \+   PS, SS, BvP
  1       163         350          F     0                                              Y                                                49:01         50:08        \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \-   \-   
  1       164         384          F     1                                              N                Paternal                        12:06         13:04        \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \-   \-   NBOs, **MMS**
  1       165         52           F     0                                              N                Paternal                        20            26           \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \+   \+   
  1       166         28           F     0                                              N                Maternal                        17:01         19           \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \+   \+   HY
  1       169         334          M     0                                              Y                                                18            19           \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \+   \+   Thor, MacroC
  1       171         405          M     0                                              Y                                                5:05          6:01         \+          \+              \-     \-               \+                                       \+                            \+     \+     \-     \-     \+   \+   
  1       172         395          M     0                                              Y                                                37:02         37:08        \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \-   \-   
  1       174         435          F     0                                              Y                                                60:02         60:09        \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \+   \+   
  1       176         463          F     0                                              Y                                                37            37:03        \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \+   \+   MacroC
  1       177         199          M     2                                              N                Paternal                        10:03         13:09        \+          \+              \+     \+               \+                                       \+                            n.a.   n.a.   \-     \-     \-   \-   PmD, SP, Cry
  1       180         340          M     0                                              Y                                                13            15           \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \-   \-   
  1       181         450          F     0                                              Y                                                15:01         16:03        \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \-   \-   
  1       182         95           M     0                                              Y                                                20            21           \+          \+              n.a.   n.a.             n.a.                                     n.a.                          \-     \-     \-     \-     \+   \+   NBOs
  1       183         146          M     0                                              Y                Paternal                        15            17           \+          \+              \+     \+               \-                                       \-                            n.a.   n.a.   \-     \-     \-   \-   HY
  1       184         166          M     1                                              N                Maternal                        24            31           \+          \+              n.a.   n.a.             \+                                       \+                            \-     \-     \-     \-     \+   \+   NBOs, LD, DLL, DS, PmD, ID, VS
  1       185         146          M     0                                              Y                                                69            76           \+          \+              n.a.   n.a.             \+                                       \+                            \-     \-     \-     \-     \+   \+   
  1       186         189          F     0                                              Y                                                28            34           \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \+   \+   NBOs, LD, SP, DS, PmD, ID, BvP, SS, Epy, AD
  1       188         255          M     0                                              Y                                                41            42           \+          \+              \+     \+               n.a.                                     n.a.                          \+     \-     \-     \-     \+   \+   **LGG**, **Malignancies**, SS
  1       190         367          F     1                                              N                Maternal                        68            70           \+          \+              \+     \+               n.a.                                     n.a.                          \-     \-     \-     \-     \+   \+   DS
  1       192         425          M     0                                              Y                                                20            22           \+          \+              \+     \+               \+                                       \+                            \+     \+     \-     \-     \+   \+   NBOs, LD, DLL, DS, MacroC, HY
  1       193         431          M     0                                              Y                                                31            36           \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \+   \+   NBOs, LD, SP, DLL, PmD, **Malignancies**, HY
  1       195         86           F     0                                              Y                                                3             20           \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   
  1       209         345          M     0                                              Y                                                4             6            \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \-   \-   
  1       211         432          M     0                                              Y                                                33            33           \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \+   \+   
  1       212         442          M     0                                              Y                                                34            36:8         \+          \+              \+     \+               n.a.                                     n.a.                          n.a.   n.a.   \-     \-     \-   \-   Dlip
  1       214         453          F     0                                              Y                                                13            14:5         \+          \+              \+     \+               \+                                       \+                            n.a.   n.a.   \-     \-     \+   \+   BvP
  1       217         470          F     0                                              Y                                                20            21           \+          \+              \+     \+               \+                                       \+                            \+     \+     \-     \-     \+   \+   NBOs
  1       218         471          M     0                                              Y                                                7             7:09         \+          \+              \-     \-               \-                                       \-                            \+     \+     \-     \-     \+   \+   NBOs, ID, SP, Noon
  1       220         480          F     0                                              Y                                                19            19           \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \+   \+   NBOS, DLL, DS, SS
  1       221         481          M     0                                              Y                                                9             10:02        \+          \+              \+     \+               \-                                       \-                            n.a.   \-     \+     \+     \-   \-   NBOs, ID, Bover
  1       222         483          M     0                                              N                                                0:08          1:06         \+          \+              \-     \-               \-                                       \-                            n.a.   n.a.   \-     \-     \-   \-   **CD**
  1       223         491          M     0                                              Y                                                37            40           \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \+   \+   DS, SF
  1       225         495          F     0                                              Y                                                8             10:01        \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   DE, VS, Noon, SS, NBOs
  1       227         500          M     0                                              Y                                                13            13           \+          \+              \+     \+               \+                                       \+                            \+     \+     \-     \-     \+   \+   
  1       233         523          F     0                                              Y                                                21            21:05        \+          \+              \-     \-               \-                                       \-                            \-     \-     \-     \-     \+   \+   
  1       234         524          M     1                                              N                Paternal                        17            18:2         \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \+   \+   **Hyd**, NA, Noon, Chem, SS
  1       241         548          M     0                                              Y                                                30            33           \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \+   \+   NBOs, LD, DS, BP
  1       247         567          M     0                                              N                Maternal                        5             7            \+          \+              \+     \+               \-                                       \-                            \+     \+     \-     \-     \+   \+   NBOs
  1       251         575          M     0                                              Y                                                10            11           \+          \+              \+     \+               \-                                       \-                            \+     \+     \-     \-     \+   \+   NBOs
  1       255         585          M     0                                              Y                                                12            13:03        \+          \+              \-     \-               \-                                       \-                            \-     \-     \-     \-     \-   \-   ID, NBOs
  1       256         592          M     0                                              Y                                                19            20           \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   
  1       259         602          M     0                                              Y                                                13            14:25        \+          \+              \+     \+               \-                                       \-                            \-     \-     \+     \+     \+   \+   AD
  1       268         632          M     0                                              Y                                                15            17           \+          \+              \-     \-               \-                                       \-                            \-     \-     \-     \-     \+   \+   
  1       276         646          M     0                                              Y                                                1             30:05        \+          \+              \-     \-               \-                                       \-                            \+     \+     \-     \-     \-   \-   
  1       277         647          M     0                                              Y                                                46            48           \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \+   \+   DLL, DS
  1       285         657          M     0                                              Y                                                51            54           \+          \+              \-     \-               \-                                       \-                            \-     \-     \-     \-     \+   \+   HY, SF
  1       288         665          M     0                                              Y                                                5             6            \+          \+              \+     \+               \-                                       \-                            n.a.   n.a.   \-     \-     \+   \+   DD, SP
  1       289         667          F     0                                              Y                                                55            58           \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \+   \+   HY, **Malignancies**
  1       292         670          M     0                                              Y                                                11            11:04        \+          \+              \+     \+               n.a.                                     n.a.                          \-     \-     \-     \-     \+   \+   NBOs, SP, LD
  1       300         681          M     0                                              Y                                                45            47           \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \+   \+   NBOs, DS
  2       36          70           M     0                                              N                Maternal                        10            12:11        \+          \+              \+     \+               \+                                       \+                            \+     \+     \-     \-     \+   \+   **RMS**, NBOs, MacroC, DS, VS
  2       61          118          M     0                                              Y                                                2:01          3:11         \+          \+              \-     \+               \-                                       \-                            \-     \-     \-     \-     \+   \+   ID, BP, MacroC, UH, Noon, Thor,
  2       64          127          M     0                                              Y                                                14:06         16:02        \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \+   \+   ID, Thor
  2       69          134          M     0                                              Y                                                16            17:02        \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \+   \+   Thor, NBOs, DLL, ID
  2       77          147          M     0                                              Y                                                4:09          6:06         \+          \+              \-     \-               \-                                       \-                            \-     \-     \-     \-     \+   \+   ID, BvP, NBOs, Thor,
  2       99          205          F     0                                              Y                                                29            29:08        \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \-   \-   ID, NBOs, **MPNST**
  2       107         227          M     0                                              Y                                                5:03          7            \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \-   \-   ID, SP, Noon, NA
  2       119         259          M     0                                              Y                                                11:02         13           \+          \+              \+     \+               \+                                       \+                            \-     \-     \-     \-     \+   \+   DE, DS, VS, ID, SP, LD, Noon, macroC, NBOs, DLL, BSL
  2       127         272          M     0                                              Y                                                15            15:09        \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \+   \+   ID, PS, Epy
  2       149         324          M     0                                              Y                                                14            16           \+          \+              \+     \+               \-                                       \-                            \+     \+     \-     \-     \+   \+   ID
  2       168         97           M     0                                              N                Paternal                        20            23           \+          \+              \+     \+               \+                                       \+                            \+     \+     \-     \-     \+   \+   ID
  3       37          71           M     0                                              Y                                                9             12:11        \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   **Leuk**
  3       42          83           M     0                                              Y                                                6             8:09         \+          \+              \-     \-               \-                                       \+                            \-     \-     \-     \-     \-   \-   
  3       45          92           F     0                                              Y                                                9:02          14:08        \+          \+              \-     \+               \-                                       \-                            \-     \-     \-     \-     \-   \+   Thor, DS, DLL
  3       47          96           F     0                                              Y                                                4:11          5:11         \+          \+              \+     \+               \-                                       \+                            \-     \-     \-     \-     \-   \-   
  3       49          100          M     0                                              Y                                                1:04          3:01         \+          \+              \-     \+               \-                                       \-                            \-     \-     \-     \-     \-   \+   BP, XG
  3       53          105          M     0                                              Y                                                8             10           \+          \+              \-     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   LD
  3       57          110          F     0                                              Y                                                3:09          4:03         \+          \+              \-     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   
  3       81          157          M     0                                              Y                                                2:01          4:11         \+          \+              \-     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   SP, Cry, NA, Thor, Noon
  3       91          180          M     0                                              Y                                                3:05          4:07         \+          \+              \-     \-               \-                                       \-                            \-     \-     \-     \-     \-   \-   DD, MacroC, SP
  3       97          203          F     0                                              Y                                                3             7:2          \+          \+              \-     \+               \-                                       \-                            \-     \-     \-     \-     \-   \+   
  3       110         238          F     0                                              Y                                                1:01          4:02         \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   
  3       113         245          F     0                                              Y                                                9:01          12:02        \+          \+              \-     \-               \-                                       \-                            \-     \-     \-     \-     \-   \-   
  3       115         249          M     0                                              Y                                                9             9:02         \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   DLL
  3       118         257          M     0                                              Y                                                5:08          8            \+          \+              \-     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   XG
  3       120         260          F     0                                              Y                                                8:08          12           \+          \+              \-     \-               \-                                       \-                            \-     \-     \-     \-     \-   \-   
  3       121         261          F     0                                              Y                                                1:09          3:05         \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   
  3       125         268          F     0                                              Y                                                3:05          3:06         \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   UH, XG
  3       128         273          M     0                                              Y                                                8:08          10:04        \+          \+              \-     \-               \-                                       \-                            \-     \-     \-     \-     \-   \-   ID, UH, Thor
  3       131         282          F     0                                              Y                                                4             6            \+          \+              \-     \-               \-                                       \-                            n.a.   n.a.   \-     \-     \-   \-   NA
  3       135         290          F     0                                              Y                                                9:03          10:01        \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   
  3       138         293          M     0                                              Y                                                5:08          5:01         \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   
  3       142         314          M     0                                              Y                                                8:06          10           \+          \+              \-     \-               \-                                       \-                            \-     \-     \-     \-     \-   \-   
  3       145         321          F     0                                              Y                                                9:01          10:01        \+          \+              \-     \-               \-                                       \-                            \-     \-     \-     \-     \-   \-   
  3       146         322          F     0                                              Y                                                6             7            \+          \+              \-     \-               \-                                       \-                            \-     \-     \-     \-     \-   \-   
  3       170         145          M     0                                              Y                                                3:05          6:02         \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   MacroC, NBOs
  3       175         358          F     0                                              Y                                                2:08          4:04         \+          \+              \-     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   SS, SP
  3       202         374          M     0                                              Y                                                8             9            \+          \+              \-     \-               \-                                       \-                            \-     \-     \-     \-     \-   \-   Thor
  3       215         464          F     0                                              Y                                                2             3:03         \+          \+              \-     \-               \-                                       \-                            \-     \-     \-     \-     \-   \-   SP, **CD**
  3       224         494          M     0                                              Y                                                9             12           \+          \+              \-     \-               \-                                       \-                            \-     \-     \-     \-     \-   \-   LD, BvP
  3       228         503          M     0                                              Y                                                2             3:08         \+          \+              \-     \-               \-                                       \-                            n.a.   n.a.   \-     \-     \-   \-   
  3       230         507          M     0                                              Y                                                7             8:03         \+          \+              \-     \-               \-                                       \-                            n.a.   n.a.   \-     \-     \-   \-   
  3       231         508          F     0                                              Y                                                1             1:03         \+          \+              \-     \-               \-                                       \-                            n.a.   n.a.   \-     \-     \-   \-   
  3       239         536          M     0                                              Y                                                5                          \+          \+              \-     \-               \-                                       \-                            n.a.   n.a.   \-     \-     \-   \-   MacroC
  3       244         555          M     0                                              Y                                                7             8:01         \+          \+              \-     \-               \-                                       \-                            \-     \-     \-     \-     \-   \-   
  3       252         576          M     0                                              Y                                                3             5            \+          \+              \+     \+               \-                                       \-                            \-     \+     \-     \-     \-   \+   ID, SP, NBOs, CIm, **MBG**, secondary Epy, DE, VS
  3       253         579          M     0                                              Y                                                7             9            \+          \+              \-     \-               \-                                       \-                            n.a.   n.a.   \-     \-     \-   \-   SP
  3       275         644          M     0                                              Y                                                6             7:02         \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \-   \+   SP, DD
  3       278         649          M     0                                              Y                                                3             3:08         \+          \+              \-     \-               \-                                       \-                            n.a.   n.a.   \-     \-     \-   \-   NA
  3       279         650          M     0                                              Y                                                2             3:25         \+          \+              \-     \-               \-                                       \-                            n.a.   n.a.   \-     \-     \-   \-   AtC
  3       282         653          M     0                                              Y                                                8             8:06         \+          \+              \+     \+               \-                                       \-                            n.a.   n.a.   \-     \-     \-   \-   
  3       294         672          F     0                                              Y                                                2             2:10         \+          \+              \-     \+               \-                                       \-                            n.a.   n.a.   \-     \-     \-   \-   **CD**
  3       297         677          F     0                                              Y                                                7             8            \+          \+              \-     \-               \-                                       \-                            n.a.   n.a.   \-     \-     \-   \-   AtC
  3       299         680          M     0                                              Y                                                6             8            \+          \+              \-     \-               \-                                       \+                            \-     \-     \-     \-     \-   \-   ID
  3       302         683          M     0                                              Y                                                1             2            \+          \+              \-     \-               \-                                       \-                            \-     \-     \-     \-     \-   \-   
  4       1           3            M     1 (twin)                                       Y                                                12            14           \+          \+              \+     \+               n.a.                                     n.a.                          \-     \-     \-     \-     \-   \-   LD
  4       5           7            M     0                                              Y                                                13:03         17           \+          \+              \-     \-               \-                                       \+                            \-     \-     \-     \-     \-   \-   Thor
  4       13          20           M     0                                              Y                                                10:07         12:08        \+          \+              \-     \-               \-                                       \+                            \-     \-     \-     \-     \-   \-   ArC, NBOs, BP, Noon, Thor, SP, **MMS**
  4       41          82           F     0                                              Y                                                16            18           \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   
  4       54          106          M     0                                              Y                                                12:03         13:01        \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   UH, NBOs
  4       56          109          M     0                                              Y                                                15:04         16:02        \+          \+              \-     \-               \-                                       \-                            \-     \-     \-     \-     \-   \-   
  4       59          113          F     0                                              Y                                                11:03         13:05        \+          \+              \-     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   DS, SS
  4       70          135          M     0                                              Y                                                17:06         18           \+          \+              \-     \-               \-                                       \-                            n.a.   n.a.   \-     \-     \-   \-   SS, BvP
  4       71          136          M     0                                              Y                                                15:07         17:05        \+          \+              \-     \-               \-                                       \-                            \-     \-     \-     \-     \-   \-   ID, SP, DLL
  4       86          163          F     0                                              Y                                                14:02         17:01        \+          \+              \-     \-               \-                                       \-                            \-     \-     \-     \-     \-   \-   LD
  4       95          198          F     1                                              Y                                                13:05         15:03        \+          \+              \-     \+               \-                                       \-                            \-     \-     \-     \-     \-   \+   
  4       96          202          F     0                                              Y                                                14:01         15           \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   
  4       106         225          M     0                                              Y                                                10:06         12:09        \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   
  4       117         251          M     0                                              Y                                                13:04         14:04        \+          \+              \-     \-               \-                                       \-                            \-     \-     \-     \-     \-   \-   Myo, AtIN
  4       123         264          M     0                                              Y                                                11            14:07        \+          \+              \-     \-               \-                                       \-                            \-     \-     \-     \-     \-   \-   
  4       130         278          M     0                                              Y                                                16:03         18:01        \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   
  4       140         306          F     0                                              Y                                                16:04         17           \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   DS, BvP, DLL
  4       143         315          F     0                                              Y                                                14:01         14:08        \+          \+              \+     \+               \-                                       \+                            \-     \-     \-     \-     \-   \-   
  4       155         339          F     0                                              Y                                                11:09         12:04        \+          \+              \-     \-               \-                                       \-                            n.a.   n.a.   \-     \-     \-   \-   MacroC, LD
  4       156         195          F     0                                              Y                                                11:03         13:09        \+          \+              \-     \-               \-                                       \-                            \-     \-     \-     \-     \-   \-   
  4       157         196          F     0                                              Y                                                11:09         14:08        \+          \+              \-     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   
  4       173         404          F     0                                              Y                                                15:01         15:07        \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   SS, MacroC
  4       196         87           F     0                                              Y                                                14            11           \+          \+              \-     \-               \-                                       \-                            n.a.   n.a.   \-     \-     \-   \-   OD
  4       201         265          M     0                                              Y                                                13            14           \+          \+              \-     \-               \-                                       \-                            n.a.   n.a.   \-     \-     \-   \-   
  4       237         532          M     0                                              Y                                                13            14           \+          \+              \-     \-               \-                                       \-                            n.a.   n.a.   \-     \-     \-   \-   
  4       245         557          F     0                                              Y                                                10            11:05        \+          \+              \-     \-               \-                                       \-                            n.a.   n.a.   \-     \-     \-   \-   NA
  4       260         608          F     0                                              Y                                                34            36           \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   
  4       269         635          M     0                                              Y                                                14            15           \+          \+              \-     \-               \-                                       \-                            n.a.   n.a.   \-     \-     \-   \-   
  4       280         651          F     0                                              Y                                                14            15           \+          \+              \-     \-               \-                                       \-                            n.a.   n.a.   \-     \-     \-   \-   
  4       281         652          M     0                                              Y                                                10            12           \+          \+              \-     \-               \-                                       \-                            n.a.   n.a.   \-     \-     \-   \-   
  4       296         675          F     0                                              Y                                                29            29           \+          \+              \-     \-               n.a.                                     n.a.                          \-     \-     \-     \-     \-   \-   
  5       11          17           M     9                                              N                Paternal                        12            15:08        \+          \+              \-     \-               \-                                       \-                            \-     \-     \-     \-     \-   \-   Cry
  5       32          170          M     3                                              N                Maternal                        12:09         12:11        \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   
  5       40          79           F     1                                              N                Maternal                        18            19:01        \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   
  5       62          121          F     0                                              N                Paternal                        8:05          12           \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   
  5       92          183          F     2                                              N                Paternal                        5             6:02         \+          \+              \-     \-               \-                                       \-                            \-     \-     \-     \-     \-   \-   NA
  5       100         212          M     0                                              N                Paternal                        15:08         17           \+          \+              \-     \-               \-                                       \-                            \-     \-     \-     \-     \-   \-   Thor
  5       101         216          F     1                                              N                Maternal                        7:06          8:02         \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   LD
  5       112         243          F     4                                              N                Paternal                        10:01         10:06        \+          \+              \-     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   Thor
  5       124         269          M     2                                              N                Maternal                        3:08          5:06         \+          \+              \-     \-               \-                                       \-                            \-     \-     \-     \-     \-   \-   UH
  5       147         323          F     2                                              N                Paternal                        3:05          4:03         \+          \+              \-     \-               \-                                       \-                            \-     \-     \-     \-     \-   \-   PS, Noon, IH
  5       161         391          F     1                                              N                Paternal                        10:01         10:04        \+          \+              \-     \-               \-                                       \-                            \-     \-     \-     \-     \-   \-   
  5       167         416          F     3                                              N                Paternal                        0:07          1:01         \+          \+              \-     \-               \-                                       \-                            \-     \-     \-     \-     \-   \-   
  5       178         492          M     1                                              N                Paternal                        5             5:03         \+          \+              \-     \-               \-                                       \-                            \-     \-     \-     \-     \-   \-   MacroC, Noon
  5       179         362          F     2                                              N                Paternal                        8:01          9:01         \+          \+              \+     \+               \-                                       \-                            \-     \-     \-     \-     \-   \-   IPP
  5       207         335          F     0                                              N                Paternal                        9             10           \+          \+              \-     \-               \-                                       \-                            n.a.   n.a.   \-     \-     \-   \-   
  5       216         638          M     2                                              N                Paternal                        1             4            \+          \+              \-     \-               \-                                       \-                            n.a.   n.a.   \-     \-     \-   \-   Chem
  5       229         504          F     3                                              N                Paternal                        9             11:09        \+          \+              \-     \-               \-                                       \-                            n.a.   n.a.   \-     \-     \-   \-   SS
  5       261         609          F     0                                              N                Maternal                        32            34           \+          \+              \+     \+               \-                                       \-                            n.a.   n.a.   \-     \-     \-   \-   Noon
  5       262                      F     0                                              N                Maternal                        28            29           \+          \+              \-     \-               \-                                       \-                            n.a.   n.a.   \-     \-     \-   \-   Noon, MacroC
  5       286         658          M     1                                              N                Maternal                        7             7:05         \+          \+              \-     \-               \-                                       \-                            n.a.   n.a.   \-     \-     \-   \-   AD

^1^ The most serious clinical features that could reduce patients' life expectancy are highlighted in bold. **Abbreviations:** AD = Attention deficit; ArC = Arachnoid cyst; AtC = Atypical CALMs; AtIN = Atypical iris nodules; Bover = Bone overgrowth; BP = Bilateral ptosis; BSL = Brain stem lesions; BvP = Behavior problems; CD = Other cardiac defects (DIA, HCM, CoA); Chem = Cherry hemangioma; CIm = Chiari I malformation; Cry = Cryptorchidism; DE = Dural ectasia; Dlip = Diffuse lipomas; DLL = Legs of different length (\>1 cm); DS = Dystrophic scoliosis; Epy = Epilepsy (idiopathic); HY = Hypertension; Hyd = Hydrocephalus; ID = Intellectual disability (moderate or severe); IH = Inguinal herniation; IPP = Idiopathic precocious puberty; LD = Learning disabilities (calculation, reading, memory); Leuk = Leukemia; LGG = Low-grade glioma (other than OPG); MacroC = Macrocephaly (\>95th PCTL or +3.33 plus 2 SD of difference with height); MBG = Multifocal brain gliomas; MLyn = Mild lymphoedema; MMS = Moyamoya syndrome; MPNST = Malignant peripheral nerve sheath tumor; Myo = Myopia; NA = Nevus anemicus; NBOs = Neurofibromatosis bright objects; Noon = Noonan-like facial features; OD = Oligodontia; OPG = Optic pathway glioma; PmD = Psychomotor delay; PS = Pulmonary stenosis; RMS = Rhabdomyosarcoma; SF = Spinal form; SP = Speech problem (needing therapy); SS = Short stature (\<3rd PCTL; \<10th PCTL general population); Thor = Thorax abnormalities (excavatum or carinatum, asymmetric); UH = Umbilical herniation; VS = Vertebral scalloping; XG = Xantogranulomas; n.a. = not available.

genes-10-00580-t0A4_Table A4

###### 

Unique variants identified in other disease genes: *KIT* (RefSeq NM_000222.2), *LZTR1* (RefSeq NM_006767.3), *NF2* (RefSeq NM_000268.3), *PPP1CB* (RefSeq NM_206876.1), *PTEN* (RefSeq NM_000314.4), *PTPN11* (RefSeq NM_002834.3), *SOS1* (RefSeq NM_005633.3), *TSC1* (RefSeq NM_000368.4), and *TSC2* (RefSeq NM_000548.3).

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Family ID ^1^   Gene       Exon       Type ^2^                                 Genomic                               cDNA                     Effect                Protein             ClinVar/HGMD/LOVD ID ^3^
  --------------- ---------- ---------- ---------------------------------------- ------------------------------------- ------------------------ --------------------- ------------------- --------------------------
  240 (1)         *KIT*      14         DEL                                      2027del                               2027del                  Frame-shift           Gly676Valfs\*4      New

  298 (1)         *LZTR1*    4          SNV                                      353G\>A                               353G\>A                  Missense              Arg118His           LOVD: LZTR1_000051

  232 (1)         *NF2*      5          DEL                                      465del                                465del                   Frame-shift           Ser156Valfs\*18     ClinVar: 547705

  238 (1)         13         SNV        1396C\>T                                 1396C\>T                              Nonsense                 Arg466\*              ClinVar: 3295       

  226 (1)         2--6       DUP        (114+1_115-1)\_(599+1_600-1)dup\         n.a.                                  Intragenic duplication   ?                     New                 
                                        (intragenic duplication ex. 2-6)                                                                                                                  

  263 (1)         *PPP1CB*   3          SNV                                      146C\>G                               146C\>G                  Missense              Pro49Arg            ClinVar: 254648

  258 (2)         *PTEN*     7          INS                                      778_779insG                           778_779insG              Frame-shift           Lys260Argfs\*38     New

  287 (1)         *PTPN11*   3          SNV                                      235C\>A                               235C\>A                  Missense              Gln79Lys            ClinVar: 44605

  242 (1)         8          SNV        923A\>G                                  923A\>G                               Missense                 Asn308Ser             ClinVar: 13327      

  191 (1)         12         SNV        1403C\>T                                 1403C\>T                              Missense                 Thr468Met             ClinVar: 13331      

  204 (1)                                                                                                                                                                                 

  257 (1)                                                                                                                                                                                 

  272 (1)                                                                                                                                                                                 

  236 (1)         13         SNV        1492C\>T                                 1492C\>T                              Missense                 Arg498Trp             ClinVar: 40553      

  301 (1)         SNV        1528C\>G   1528C\>G                                 Missense                              Gln510Glu                ClinVar: 40566                            

  270 (1)         *SOS1*     4          SNV                                      429G\>T                               429G\>T                  Missense              Lys143Asn           New

  187 (2)         10         SNV        1642A\>C                                 1642A\>C                              Missense                 Ser548Arg             LOVD: SOS1_000142   

  189 (2)         *TSC1*     13         DEL                                      1326_1327del                          1326_1327del             Frame-shift           Gly443Ilefs\*15     ClinVar: 421669

  265 (1)         18         SNV        2293C\>T                                 2293C\>T                              Nonsense                 Gln765\*              ClinVar: 48934      

  274 (1)         19         INS        2421dup                                  2421dup                               Frame-shift              Ala808Cysfs\*18       LOVD: TSC1_00419    

  305 (1)         *TSC2*     1--16      DEL                                      (-30+1\_-29-1)\_(1716+1_1717-1)del\   n.a.                     Intragenic deletion   ?                   New
                                                                                 (intragenic deletion ex. 1-16)                                                                           

  267 (1)         1--22      DEL        c.(-30+1\_-29-1)\_(2545+1_2546-1)del\    n.a.                                  Intragenic deletion      ?                     New                 
                                        (intragenic deletion ex. 1-22)                                                                                                                    

  295 (1)         7          SNV        648+1G\>T                                n.a.                                  Splicing                 ?                     LOVD: TSC2_03572    

  303 (1)         37         DEL        c.(4662+1_4663-1)\_(4849+1_4850-1)del\   n.a.                                  Intragenic deletion      ?                     LOVD: TSC2_03465    
                                        (intragenic deletion ex. 37)                                                                                                                      

  248 (1)         41         DEL        5238_5255del                             5238_5255del                          In-frame deletion        His1746_Arg1751del    LOVD: TSC2_00149    
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^1^ Number of family members presenting the variant is reported in parentheses; ^2^ Type of variant: SNV = Single-nucleotide variant, DEL = Deletion, DUP = Duplication, INS = Insertion. ^3^ ID of annotated variants in ClinVar ([www.ncbi.nlm.nih.gov/clinvar](www.ncbi.nlm.nih.gov/clinvar)), Human Genome Variation Database (HGMD; [www.hgmd.cf.ac.uk](www.hgmd.cf.ac.uk)) and Leiden Open Variation Database (LOVD; [databases.lovd.nl/shared/genes](databases.lovd.nl/shared/genes)).
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###### 

Results of the molecular diagnosis by patient group.

  Group   Criteria for Molecular Testing                                                      Number of Selected Patients   Number of Mutated Patients                    Mutation Detection Rate (%)                              Number of Patients without Molecular Diagnosis (%)
  ------- ----------------------------------------------------------------------------------- ----------------------------- --------------------------------------------- -------------------------------------------------------- ----------------------------------------------------
  1       Clinical diagnosis of NF1 (test requested by parents or milder phenotype)           139                           136 (*NF1* = 136; *SPRED1* = 0; OTHER = 0)    97.8% (*NF1* = 97.8%; *SPRED1* = 0.0%; OTHER = 0.0%)     3 (2.2%)
  2       Severe NF1 phenotype with suspicion of 17q11.2 microdeletion                        11                            11 (*NF1* = 11; *SPRED1* = 0; OTHER = 0)      100.0% (*NF1* = 100.0%; *SPRED1* = 0.0%; OTHER = 0.0%)   0 (0.0%)
  3       Isolated CALMs in patients without affected first-degree relatives and age ≤ 9 y    44                            29 (*NF1* = 28; *SPRED1* = 1; OTHER = 0)      65.9% (*NF1* = 63.6%; *SPRED1* = 2.3%; OTHER = 0.0%)     15 (34.1%)
  4       Isolated CALMs in patients without affected first-degree relatives and age ≥ 10 y   31                            20 (*NF1* = 19; *SPRED1* = 1; OTHER = 0)      64.5% (*NF1* = 61.3%; *SPRED1* = 3.2%; OTHER = 0.0%)     11 (35.5%)
  5       Isolated CALMs in patients and at least one affected first-degree relative          20                            17 (*NF1* = 11; *SPRED1* = 6; OTHER = 0)      85.0% (*NF1* = 55.0%; *SPRED1* = 30.0%; OTHER = 0.0%)    3 (15.0%)
  6       Other RASopathies or neurocutaneous disorders                                       36                            26 (*NF1* = 1; *SPRED1* = 0; OTHER = 25)      72.2% (*NF1* = 2.7%; *SPRED1* = 0.0%; OTHER = 69.4%)     10 (27.8%)
          Total                                                                               281                           239 (*NF1* = 206; *SPRED1* = 8; OTHER = 25)   85.0% (*NF1* = 73.3%; *SPRED1* = 2.8%; OTHER = 8.9%)     42 (15.0%)

Notes: NF1 = neurofibromatosis type 1; CALMs = café au lait macules; OTHER = other disease genes investigated (the identified causative variants are reported in [Table A4](#genes-10-00580-t0A4){ref-type="table"}).

[^1]: Both authors contributed equally to this work.
